data_2lfe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m . . . . . 0 C--O 1.235 0.325 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.522 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.502 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.502 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' O ' ' HE1' ' A' ' 132' ' ' MET . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.54 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.44 ' HA ' ' HE2' ' A' ' 132' ' ' MET . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.642 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 158' ' ' THR . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.444 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.416 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.49 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.417 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.618 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.618 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.402 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.423 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.44 ' HG3' HG23 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.515 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.495 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.539 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 HD21 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.623 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 120.532 0.206 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.623 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HG ' ' HB2' ' A' ' 152' ' ' ALA . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HB2' HD23 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.48 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.703 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.703 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.7 m120 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.569 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.48 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.545 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.581 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.581 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.417 HG22 HG21 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 61' ' ' LEU . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-O 120.304 0.097 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.516 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.401 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.497 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.416 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 70' ' ' LEU . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.604 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.438 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.516 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.485 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.548 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HA ' ' HZ1' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.485 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.543 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.543 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.585 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.476 HG22 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.505 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.778 0.323 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.513 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.499 HD22 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.487 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.647 ' HZ3' ' HB2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HB2' ' HZ3' ' A' ' 83' ' ' LYS . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.555 HG13 HG13 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.451 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.555 HG13 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.517 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.513 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.517 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.681 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HG ' HG22 ' A' ' 154' ' ' THR . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.47 HG13 HG13 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.5 m120 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.597 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG13 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 133' ' ' GLU . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.509 HG21 HG23 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 . . . . . 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.688 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.459 HG22 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.595 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.693 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.501 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.545 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.419 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.693 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 149' ' ' ALA . 66.1 t60 . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.578 ' HB2' HD22 ' A' ' 70' ' ' LEU . 2.9 t-20 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.521 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 69' ' ' THR . 21.5 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 16.9 m120 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.556 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.493 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.482 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.525 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.58 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.596 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.461 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 . . . . . 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.432 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.598 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.515 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.469 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.482 ' HB2' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.458 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HA ' HG12 ' A' ' 136' ' ' ILE . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.636 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.577 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.577 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.515 ' HD1' ' HB3' ' A' ' 90' ' ' ASP . 79.7 t60 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.563 0.22 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.598 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 82' ' ' ILE . 12.9 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.527 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.432 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 m120 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.527 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.561 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.489 ' HD1' ' HB2' ' A' ' 151' ' ' ARG . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 t60 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.426 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 127' ' ' PRO . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.421 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG22 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.4 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.4 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' HD11 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.643 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.643 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.471 ' HB ' HD23 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.522 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.606 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.487 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.606 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.405 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.437 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.456 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.501 HG23 HG13 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.515 0.198 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.465 ' HB3' HD13 ' A' ' 82' ' ' ILE . 25.9 m . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.504 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG13 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.504 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HG2' HG22 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.661 HH12 HG13 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 160' ' ' LYS . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.241 0.639 0 CA-C-O 120.53 0.205 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.435 HD11 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.409 ' O ' HD22 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.466 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.9 m120 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD11 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.462 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.466 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.415 0.15 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.462 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -98.91 169.94 9.09 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.489 0.715 . . . . 0.0 111.108 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m -71.05 133.45 46.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.6 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HZ3' ' HA2' ' A' ' 145' ' ' GLY . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.522 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.502 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.502 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' O ' ' HE1' ' A' ' 132' ' ' MET . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.54 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.44 ' HA ' ' HE2' ' A' ' 132' ' ' MET . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.642 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -78.14 116.6 18.71 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.409 ' HA2' ' HZ3' ' A' ' 91' ' ' TRP . . . -49.43 -35.21 20.93 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.485 1.116 . . . . 0.0 115.699 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.62 112.32 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t 72.56 -3.18 2.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.2 40.4 97.24 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.64 122.07 26.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.75 0.82 . . . . 0.0 110.309 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -105.91 161.4 14.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.225 0.61 . . . . 0.0 110.69 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p -71.34 111.05 6.36 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.945 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 158' ' ' THR . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.416 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.446 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.49 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.417 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.618 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.618 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -95.51 144.82 25.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . -60.9 -46.12 95.18 Favored Glycine 0 C--N 1.341 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 113.36 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.29 131.44 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.6 m 72.23 -18.0 0.35 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.404 1.482 . . . . 0.0 114.057 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.72 76.77 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -168.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.06 118.88 21.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 111.392 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.402 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.423 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.44 ' HG3' HG23 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -102.12 178.01 4.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.185 0.517 . . . . 0.0 112.145 -170.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.515 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m -58.11 141.4 50.33 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.375 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.495 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.539 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 HD21 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.623 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 -121.76 139.03 54.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.83 -139.17 32.51 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.943 0.777 . . . . 0.0 111.692 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.6 mt -96.25 82.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.6 p 51.72 34.46 13.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.658 1.583 . . . . 0.0 113.123 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.29 -92.91 0.96 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.722 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . -78.98 110.62 14.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.196 0.598 . . . . 0.0 111.124 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.623 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.01 -173.16 2.69 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.807 1.243 . . . . 0.0 110.11 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m -46.57 115.4 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.485 1.114 . . . . 0.0 113.006 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HG ' ' HB2' ' A' ' 152' ' ' ALA . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HB2' HD23 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.568 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.48 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.703 ' HD1' ' HB2' ' A' ' 98' ' ' ASP . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.703 ' HB2' ' HD1' ' A' ' 96' ' ' HIS . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.7 m120 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.569 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.48 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.545 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.581 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.581 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.417 HG22 HG21 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -120.31 125.64 48.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.568 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . 67.66 -175.3 26.69 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.706 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.6 tt -83.08 71.17 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-O 122.4 1.095 . . . . 0.0 108.989 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.5 t -161.58 174.92 12.66 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.599 -173.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.98 27.75 9.68 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.495 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.84 105.75 7.05 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.156 0.582 . . . . 0.0 109.431 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 61' ' ' LEU . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 6.5 ppt_? -153.9 -177.94 6.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.138 0.975 . . . . 0.0 111.04 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m -58.06 110.64 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.55 0.74 . . . . 0.0 110.907 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.516 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.497 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.416 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 70' ' ' LEU . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.438 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.516 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -81.07 160.59 24.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.55 -30.48 65.34 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.543 0.527 . . . . 0.0 113.995 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.44 98.01 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.8 p -60.45 110.3 1.23 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.136 0.974 . . . . 0.0 111.52 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.8 -36.51 2.62 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.44 111.41 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.414 0.686 . . . . 0.0 110.264 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.16 147.69 35.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.324 0.65 . . . . 0.0 109.628 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m -64.82 112.6 3.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 0.0 111.535 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.465 ' HB3' HD23 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.485 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.548 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HA ' ' HZ1' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.485 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.543 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.543 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.585 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.476 HG22 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.505 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -127.47 109.7 12.01 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.67 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . 91.08 159.25 35.47 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.666 0.604 . . . . 0.0 112.568 -175.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.2 mm -68.56 109.84 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.035 0.934 . . . . 0.0 109.625 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.2 m 63.69 21.52 12.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.546 1.139 . . . . 0.0 111.24 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.23 -172.65 44.96 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.46 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 146.73 53.13 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.676 0.79 . . . . 0.0 111.813 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -124.68 168.06 13.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.247 0.619 . . . . 0.0 111.602 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p -105.85 110.16 22.36 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.09 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.513 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.499 HD22 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.487 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.647 ' HZ3' ' HB2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HB2' ' HZ3' ' A' ' 83' ' ' LYS . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.555 HG13 HG13 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.451 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.555 HG13 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.517 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.513 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.517 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.681 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.14 167.08 11.59 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 87' ' ' ASP . . . -63.92 -32.75 85.23 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.13 107.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.411 0.624 . . . . 0.0 109.538 163.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -56.71 128.04 34.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.137 1.375 . . . . 0.0 112.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.41 -13.04 68.06 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.878 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.99 108.27 16.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.704 0.252 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -88.73 179.33 6.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.726 0.81 . . . . 0.0 111.797 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -65.59 135.52 55.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.171 0.988 . . . . 0.0 111.773 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HG ' HG22 ' A' ' 154' ' ' THR . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.465 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.47 HG13 HG13 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.5 m120 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.597 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG13 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 HD12 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 133' ' ' GLU . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.509 HG21 HG23 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.37 143.22 26.97 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . -78.16 -57.1 3.52 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.249 0.343 . . . . 0.0 112.414 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.51 103.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.5 t 67.35 112.36 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 O-C-N 124.194 0.934 . . . . 0.0 108.901 -167.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.69 48.32 3.67 Favored Glycine 0 C--N 1.353 1.495 0 C-N-CA 123.351 0.501 . . . . 0.0 114.324 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.11 145.33 24.77 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.763 0.825 . . . . 0.0 110.538 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.459 HG22 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.595 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.57 179.77 5.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.372 0.669 . . . . 0.0 111.113 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m -59.46 111.53 1.43 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.693 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.501 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.545 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.419 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.693 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 149' ' ' ALA . 66.1 t60 -111.66 102.07 10.4 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.33 -74.57 0.69 Allowed Glycine 0 C--N 1.346 1.111 0 O-C-N 123.982 0.801 . . . . 0.0 112.635 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.6 mt -109.82 162.6 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 125.287 1.435 . . . . 0.0 108.36 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 p -77.04 80.49 3.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.159 0.584 . . . . 0.0 110.496 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.44 -65.9 0.01 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 144' ' ' HIS . . . -73.96 109.52 7.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.307 0.643 . . . . 0.0 109.471 173.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.578 ' HB2' HD22 ' A' ' 70' ' ' LEU . 2.9 t-20 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.469 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 22.9 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -126.83 137.66 53.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.362 0.665 . . . . 0.0 110.203 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m -68.86 111.15 4.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.42 0.688 . . . . 0.0 109.693 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.521 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 69' ' ' THR . 21.5 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 16.9 m120 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.556 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.493 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.482 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.525 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.58 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.596 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.415 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.461 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -81.73 169.42 16.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.28 -30.88 49.32 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 123.428 0.537 . . . . 0.0 113.961 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.89 109.6 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 p -63.83 96.42 0.13 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 110.653 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 143.6 -39.23 1.3 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.08 120.77 14.24 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.881 0.872 . . . . 0.0 109.846 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -125.52 -177.71 3.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.22 1.008 . . . . 0.0 110.806 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m -44.38 128.97 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.319 1.447 . . . . 0.0 111.985 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.598 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.515 ' HB3' ' HD1' ' A' ' 144' ' ' HIS . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.512 ' HH2' ' H ' ' A' ' 147' ' ' SER . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.469 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.482 ' HB2' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.458 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HA ' HG12 ' A' ' 136' ' ' ILE . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.636 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.577 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.577 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.515 ' HD1' ' HB3' ' A' ' 90' ' ' ASP . 79.7 t60 -129.78 118.12 21.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.17 153.25 28.31 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.1 pt -60.23 87.08 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 123.875 0.87 . . . . 0.0 112.221 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.512 ' H ' ' HH2' ' A' ' 91' ' ' TRP . 22.7 t 62.6 29.25 16.92 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.206 1.403 . . . . 0.0 111.014 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.32 -107.4 0.78 Allowed Glycine 0 C--N 1.355 1.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.074 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 161.21 21.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.617 0.767 . . . . 0.0 111.353 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.598 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 179.9 3.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.372 0.669 . . . . 0.0 111.637 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 82' ' ' ILE . 12.9 m -51.12 118.34 3.15 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.405 1.482 . . . . 0.0 111.145 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.527 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.44 ' HH2' ' HA2' ' A' ' 148' ' ' GLY . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.432 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 m120 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.527 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.561 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.489 ' HD1' ' HB2' ' A' ' 151' ' ' ARG . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -76.16 140.57 41.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.31 -72.83 0.45 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 124.6 1.187 . . . . 0.0 115.044 -170.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mt -90.82 66.86 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.2 m -160.9 -57.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.368 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.44 ' HA2' ' HH2' ' A' ' 91' ' ' TRP . . . 90.02 -21.48 30.6 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.202 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.23 158.91 24.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.634 0.774 . . . . 0.0 111.64 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 22.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.74 170.11 9.68 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -59.95 121.21 11.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.224 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.426 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 127' ' ' PRO . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' SER . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.421 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD23 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.522 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG22 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.4 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.4 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' HD11 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.643 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.643 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.471 ' HB ' HD23 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -123.91 87.42 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.7 -74.3 0.76 Allowed Glycine 0 C--N 1.343 0.969 0 O-C-N 123.985 0.803 . . . . 0.0 113.518 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.58 133.16 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 124.306 1.042 . . . . 0.0 110.823 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -71.32 84.68 0.79 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.387 0.675 . . . . 0.0 109.878 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.03 -31.12 0.73 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.374 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.67 106.57 9.56 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.239 0.541 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -83.14 177.59 8.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.766 0.826 . . . . 0.0 109.901 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.606 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m -69.27 112.6 5.95 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.605 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.487 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.606 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 146' ' ' ILE . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.405 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.437 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.456 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.501 HG23 HG13 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 106.11 8.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.97 165.1 40.46 Favored Glycine 0 C--O 1.244 0.758 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.496 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 91' ' ' TRP . 65.6 mt -63.88 97.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.371 0.668 . . . . 0.0 109.658 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p 50.39 44.19 26.76 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.454 1.502 . . . . 0.0 111.439 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.21 -126.41 5.34 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.295 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.75 162.75 28.98 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.095 0.958 . . . . 0.0 111.114 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 58' ' ' ARG . 3.3 mpt_? -93.09 179.1 5.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.256 0.622 . . . . 0.0 110.727 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.465 ' HB3' HD13 ' A' ' 82' ' ' ILE . 25.9 m -62.16 126.38 27.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.533 176.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.504 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG13 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.442 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.504 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HG2' HG22 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -82.38 148.1 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . -60.57 -45.26 96.66 Favored Glycine 0 C--N 1.347 1.183 0 O-C-N 123.636 0.585 . . . . 0.0 113.192 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 mm -65.31 118.62 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.72 0.408 . . . . 0.0 109.976 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t 70.3 -5.49 1.34 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.264 1.426 . . . . 0.0 113.317 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.08 28.6 70.83 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 117.674 0.216 . . . . 0.0 112.977 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.87 139.01 50.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.511 0.724 . . . . 0.0 111.31 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.661 HH12 HG13 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 160' ' ' LYS . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 145.0 30.04 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.868 0.867 . . . . 0.0 109.521 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m -69.66 127.34 32.61 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.58 0.752 . . . . 0.0 110.601 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.435 HD11 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.409 ' O ' HD22 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.466 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.9 m120 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD11 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.462 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.466 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -92.28 166.74 12.45 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.18 -18.04 33.3 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 114.75 0.66 . . . . 0.0 114.75 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.12 132.25 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -62.87 108.85 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.98 -9.03 70.46 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.938 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.36 109.47 6.91 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.077 0.551 . . . . 0.0 110.739 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.462 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m . . . . . 0 C--O 1.235 0.325 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.508 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.651 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.651 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.533 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 142' ' ' TYR . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 115' ' ' GLY . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.497 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.46 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.625 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.603 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.503 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' H ' HD11 ' A' ' 61' ' ' LEU . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.446 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 142' ' ' TYR . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.574 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.546 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.476 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 120.532 0.206 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.625 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 76' ' ' LEU . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-O 120.304 0.097 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.419 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.424 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.647 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 ' HB1' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.473 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.423 HD11 ' SG ' ' A' ' 139' ' ' CYS . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.577 ' NZ ' ' HA ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.552 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.552 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.525 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.778 0.323 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.403 HG23 ' HG2' ' A' ' 141' ' ' LYS . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.528 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.474 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.615 HG13 HG11 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.474 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.528 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.686 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.686 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.558 ' HB3' HD11 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.425 ' HB2' HD21 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG13 HG11 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.61 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.429 ' HE1' HD22 ' A' ' 76' ' ' LEU . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.521 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.621 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 138' ' ' ILE . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 . . . . . 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.688 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.621 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.413 ' HE3' ' HD2' ' A' ' 68' ' ' TYR . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.413 ' HD2' ' HE3' ' A' ' 65' ' ' MET . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.706 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.49 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.706 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 66.1 t60 . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.594 ' HB2' HD23 ' A' ' 70' ' ' LEU . 63.9 t30 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.48 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.487 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.584 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.586 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.586 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.417 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 . . . . . 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 157' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 84' ' ' GLU . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.63 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.488 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.455 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 HD11 HD12 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 79.7 t60 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.563 0.22 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.63 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 12.9 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 HG23 ' A' ' 122' ' ' VAL . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.51 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG13 HD12 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.51 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.401 HG23 HG12 ' A' ' 77' ' ' ILE . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 t60 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.408 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HA ' HH22 ' A' ' 124' ' ' ARG . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.408 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.41 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.533 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.414 HH22 ' HA ' ' A' ' 73' ' ' ALA . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 70' ' ' LEU . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' HD12 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.533 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.507 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.6 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 108' ' ' SER . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' A' ' 94' ' ' LEU . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.459 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 HG11 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.414 HG21 ' HD1' ' A' ' 131' ' ' PHE . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HG2' HG23 ' A' ' 153' ' ' THR . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.515 0.198 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.524 HG11 HG21 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 82' ' ' ILE . 25.9 m . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.494 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.494 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HD22 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.485 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.704 HH12 HG12 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.241 0.639 0 CA-C-O 120.53 0.205 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 HD12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 159' ' ' VAL . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.415 0.15 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.459 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -98.91 169.94 9.09 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.489 0.715 . . . . 0.0 111.108 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m -71.05 133.45 46.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.6 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.411 ' HZ3' ' HA2' ' A' ' 145' ' ' GLY . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.508 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.651 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.651 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.533 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -78.14 116.6 18.71 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.411 ' HA2' ' HZ3' ' A' ' 91' ' ' TRP . . . -49.43 -35.21 20.93 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.485 1.116 . . . . 0.0 115.699 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.62 112.32 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t 72.56 -3.18 2.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.2 40.4 97.24 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.64 122.07 26.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.75 0.82 . . . . 0.0 110.309 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -105.91 161.4 14.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.225 0.61 . . . . 0.0 110.69 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p -71.34 111.05 6.36 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.945 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 142' ' ' TYR . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 115' ' ' GLY . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.495 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.497 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.46 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.625 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.603 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' H ' HD11 ' A' ' 61' ' ' LEU . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -95.51 144.82 25.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . -60.9 -46.12 95.18 Favored Glycine 0 C--N 1.341 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 113.36 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.29 131.44 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.6 m 72.23 -18.0 0.35 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.404 1.482 . . . . 0.0 114.057 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.72 76.77 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -168.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.06 118.88 21.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 111.392 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.446 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -102.12 178.01 4.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.185 0.517 . . . . 0.0 112.145 -170.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m -58.11 141.4 50.33 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.375 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 142' ' ' TYR . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.574 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.546 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.476 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 -121.76 139.03 54.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.83 -139.17 32.51 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.943 0.777 . . . . 0.0 111.692 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.6 mt -96.25 82.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.6 p 51.72 34.46 13.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.658 1.583 . . . . 0.0 113.123 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.29 -92.91 0.96 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.722 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . -78.98 110.62 14.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.196 0.598 . . . . 0.0 111.124 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.625 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 76' ' ' LEU . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.01 -173.16 2.69 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.807 1.243 . . . . 0.0 110.11 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m -46.57 115.4 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.485 1.114 . . . . 0.0 113.006 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.573 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -120.31 125.64 48.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.573 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . 67.66 -175.3 26.69 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.706 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.6 tt -83.08 71.17 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-O 122.4 1.095 . . . . 0.0 108.989 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.5 t -161.58 174.92 12.66 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.599 -173.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.98 27.75 9.68 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.495 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.84 105.75 7.05 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.156 0.582 . . . . 0.0 109.431 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 6.5 ppt_? -153.9 -177.94 6.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.138 0.975 . . . . 0.0 111.04 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m -58.06 110.64 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.55 0.74 . . . . 0.0 110.907 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.419 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.424 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.647 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -81.07 160.59 24.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.55 -30.48 65.34 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.543 0.527 . . . . 0.0 113.995 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.44 98.01 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.8 p -60.45 110.3 1.23 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.136 0.974 . . . . 0.0 111.52 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.8 -36.51 2.62 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.44 111.41 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.414 0.686 . . . . 0.0 110.264 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.16 147.69 35.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.324 0.65 . . . . 0.0 109.628 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m -64.82 112.6 3.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 0.0 111.535 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 ' HB1' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.473 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.692 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.423 HD11 ' SG ' ' A' ' 139' ' ' CYS . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.577 ' NZ ' ' HA ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.552 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.552 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.525 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -127.47 109.7 12.01 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.692 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . 91.08 159.25 35.47 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.666 0.604 . . . . 0.0 112.568 -175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.2 mm -68.56 109.84 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.035 0.934 . . . . 0.0 109.625 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.2 m 63.69 21.52 12.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.546 1.139 . . . . 0.0 111.24 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.23 -172.65 44.96 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.46 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 146.73 53.13 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.676 0.79 . . . . 0.0 111.813 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.403 HG23 ' HG2' ' A' ' 141' ' ' LYS . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -124.68 168.06 13.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.247 0.619 . . . . 0.0 111.602 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p -105.85 110.16 22.36 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.09 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.528 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.474 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.615 HG13 HG11 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.474 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.528 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.686 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.686 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.558 ' HB3' HD11 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.425 ' HB2' HD21 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.14 167.08 11.59 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 87' ' ' ASP . . . -63.92 -32.75 85.23 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.13 107.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.411 0.624 . . . . 0.0 109.538 163.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -56.71 128.04 34.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.137 1.375 . . . . 0.0 112.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.41 -13.04 68.06 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.878 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.99 108.27 16.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.704 0.252 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -88.73 179.33 6.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.726 0.81 . . . . 0.0 111.797 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -65.59 135.52 55.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.171 0.988 . . . . 0.0 111.773 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.472 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG13 HG11 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.61 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.429 ' HE1' HD22 ' A' ' 76' ' ' LEU . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.521 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.621 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 138' ' ' ILE . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.37 143.22 26.97 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . -78.16 -57.1 3.52 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.249 0.343 . . . . 0.0 112.414 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.51 103.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.5 t 67.35 112.36 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 O-C-N 124.194 0.934 . . . . 0.0 108.901 -167.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.69 48.32 3.67 Favored Glycine 0 C--N 1.353 1.495 0 C-N-CA 123.351 0.501 . . . . 0.0 114.324 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.11 145.33 24.77 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.763 0.825 . . . . 0.0 110.538 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.621 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.57 179.77 5.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.372 0.669 . . . . 0.0 111.113 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m -59.46 111.53 1.43 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.413 ' HE3' ' HD2' ' A' ' 68' ' ' TYR . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.413 ' HD2' ' HE3' ' A' ' 65' ' ' MET . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.41 ' HB2' ' HA2' ' A' ' 145' ' ' GLY . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.706 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.49 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.706 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 66.1 t60 -111.66 102.07 10.4 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 89' ' ' SER . . . 71.33 -74.57 0.69 Allowed Glycine 0 C--N 1.346 1.111 0 O-C-N 123.982 0.801 . . . . 0.0 112.635 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.6 mt -109.82 162.6 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 125.287 1.435 . . . . 0.0 108.36 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 p -77.04 80.49 3.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.159 0.584 . . . . 0.0 110.496 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.44 -65.9 0.01 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . -73.96 109.52 7.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.307 0.643 . . . . 0.0 109.471 173.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.594 ' HB2' HD23 ' A' ' 70' ' ' LEU . 63.9 t30 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 22.9 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -126.83 137.66 53.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.362 0.665 . . . . 0.0 110.203 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m -68.86 111.15 4.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.42 0.688 . . . . 0.0 109.693 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.48 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.487 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.584 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.586 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.586 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.417 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -81.73 169.42 16.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.28 -30.88 49.32 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 123.428 0.537 . . . . 0.0 113.961 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.89 109.6 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 p -63.83 96.42 0.13 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 110.653 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 143.6 -39.23 1.3 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.08 120.77 14.24 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.881 0.872 . . . . 0.0 109.846 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -125.52 -177.71 3.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.22 1.008 . . . . 0.0 110.806 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m -44.38 128.97 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.319 1.447 . . . . 0.0 111.985 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 157' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 84' ' ' GLU . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.63 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HH2' ' H ' ' A' ' 147' ' ' SER . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.488 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.455 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 HD11 HD12 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -129.78 118.12 21.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.17 153.25 28.31 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.1 pt -60.23 87.08 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 123.875 0.87 . . . . 0.0 112.221 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.578 ' H ' ' HH2' ' A' ' 91' ' ' TRP . 22.7 t 62.6 29.25 16.92 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.206 1.403 . . . . 0.0 111.014 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.32 -107.4 0.78 Allowed Glycine 0 C--N 1.355 1.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.074 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 161.21 21.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.617 0.767 . . . . 0.0 111.353 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.63 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 179.9 3.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.372 0.669 . . . . 0.0 111.637 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 12.9 m -51.12 118.34 3.15 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.405 1.482 . . . . 0.0 111.145 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 HG23 ' A' ' 122' ' ' VAL . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.51 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.446 ' HH2' ' HA2' ' A' ' 148' ' ' GLY . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG13 HD12 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.51 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.401 HG23 HG12 ' A' ' 77' ' ' ILE . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -76.16 140.57 41.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.31 -72.83 0.45 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 124.6 1.187 . . . . 0.0 115.044 -170.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mt -90.82 66.86 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.2 m -160.9 -57.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.368 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.446 ' HA2' ' HH2' ' A' ' 91' ' ' TRP . . . 90.02 -21.48 30.6 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.202 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.23 158.91 24.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.634 0.774 . . . . 0.0 111.64 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 22.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.74 170.11 9.68 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -59.95 121.21 11.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.224 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.408 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HA ' HH22 ' A' ' 124' ' ' ARG . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.408 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' SER . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.41 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.533 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.414 HH22 ' HA ' ' A' ' 73' ' ' ALA . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 70' ' ' LEU . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' HD12 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.533 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -123.91 87.42 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.7 -74.3 0.76 Allowed Glycine 0 C--N 1.343 0.969 0 O-C-N 123.985 0.803 . . . . 0.0 113.518 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.58 133.16 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 124.306 1.042 . . . . 0.0 110.823 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -71.32 84.68 0.79 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.387 0.675 . . . . 0.0 109.878 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.03 -31.12 0.73 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.374 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.67 106.57 9.56 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.239 0.541 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -83.14 177.59 8.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.766 0.826 . . . . 0.0 109.901 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m -69.27 112.6 5.95 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.605 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.507 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.6 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' HZ3' ' HA ' ' A' ' 146' ' ' ILE . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 108' ' ' SER . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' A' ' 94' ' ' LEU . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.459 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 HG11 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.414 HG21 ' HD1' ' A' ' 131' ' ' PHE . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HG2' HG23 ' A' ' 153' ' ' THR . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 106.11 8.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.97 165.1 40.46 Favored Glycine 0 C--O 1.244 0.758 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.496 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' ' HZ3' ' A' ' 91' ' ' TRP . 65.6 mt -63.88 97.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.371 0.668 . . . . 0.0 109.658 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p 50.39 44.19 26.76 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.454 1.502 . . . . 0.0 111.439 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.21 -126.41 5.34 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.295 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.75 162.75 28.98 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.095 0.958 . . . . 0.0 111.114 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.524 HG11 HG21 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 58' ' ' ARG . 3.3 mpt_? -93.09 179.1 5.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.256 0.622 . . . . 0.0 110.727 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 82' ' ' ILE . 25.9 m -62.16 126.38 27.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.533 176.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.494 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.494 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HD22 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.485 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -82.38 148.1 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . -60.57 -45.26 96.66 Favored Glycine 0 C--N 1.347 1.183 0 O-C-N 123.636 0.585 . . . . 0.0 113.192 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 mm -65.31 118.62 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.72 0.408 . . . . 0.0 109.976 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t 70.3 -5.49 1.34 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.264 1.426 . . . . 0.0 113.317 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.08 28.6 70.83 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 117.674 0.216 . . . . 0.0 112.977 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.87 139.01 50.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.511 0.724 . . . . 0.0 111.31 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.704 HH12 HG12 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 145.0 30.04 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.868 0.867 . . . . 0.0 109.521 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m -69.66 127.34 32.61 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.58 0.752 . . . . 0.0 110.601 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 HD12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 159' ' ' VAL . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -92.28 166.74 12.45 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.18 -18.04 33.3 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 114.75 0.66 . . . . 0.0 114.75 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.12 132.25 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -62.87 108.85 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.98 -9.03 70.46 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.938 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.36 109.47 6.91 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.077 0.551 . . . . 0.0 110.739 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.459 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m . . . . . 0 C--O 1.235 0.325 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.508 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.651 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.651 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.533 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 142' ' ' TYR . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 115' ' ' GLY . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.497 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.46 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.625 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.603 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.503 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' H ' HD11 ' A' ' 61' ' ' LEU . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 . . . . . 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.446 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 142' ' ' TYR . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.574 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.546 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.476 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 120.532 0.206 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.625 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 76' ' ' LEU . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB3' HD21 ' A' ' 104' ' ' ASN . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 100' ' ' ASN . 12.7 m120 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-O 120.304 0.097 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.419 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.424 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.647 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.661 0.267 . . . . 0.0 111.535 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 ' HB1' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.473 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.423 HD11 ' SG ' ' A' ' 139' ' ' CYS . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.577 ' HA ' ' NZ ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 86' ' ' VAL . 21.0 mm-40 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.552 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.552 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.525 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.778 0.323 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.403 HG23 ' HG2' ' A' ' 141' ' ' LYS . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.528 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.474 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.615 HG13 HG11 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.474 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.528 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.686 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.686 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.558 ' HB3' HD11 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.425 ' HB2' HD21 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG13 HG11 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.5 m120 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.61 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.429 ' HE1' HD22 ' A' ' 76' ' ' LEU . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.521 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.621 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 138' ' ' ILE . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 . . . . . 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.688 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.621 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.413 ' HE3' ' HD2' ' A' ' 68' ' ' TYR . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.413 ' HD2' ' HE3' ' A' ' 65' ' ' MET . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.706 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.49 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.706 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 66.1 t60 . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.594 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.9 t-20 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 69' ' ' THR . 21.5 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 16.9 m120 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.48 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.487 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.584 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.586 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.586 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.417 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 . . . . . 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 157' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 84' ' ' GLU . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.63 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.488 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.43 HE21 HG22 ' A' ' 86' ' ' VAL . 15.5 mm-40 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.455 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 HD11 HD12 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 79.7 t60 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.563 0.22 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.63 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 12.9 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 HG23 ' A' ' 122' ' ' VAL . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.51 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 m120 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG13 HD12 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.51 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.401 HG23 HG12 ' A' ' 77' ' ' ILE . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 t60 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.408 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HA ' HH22 ' A' ' 124' ' ' ARG . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.408 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.41 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.533 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.414 HH22 ' HA ' ' A' ' 73' ' ' ALA . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 70' ' ' LEU . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' HD12 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.533 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.507 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.6 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 108' ' ' SER . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' A' ' 94' ' ' LEU . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.459 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 HG11 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.414 HG21 ' HD1' ' A' ' 131' ' ' PHE . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HG2' HG23 ' A' ' 153' ' ' THR . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.515 0.198 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.524 HG11 HG21 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 82' ' ' ILE . 25.9 m . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.494 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.494 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HD22 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.485 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.704 HH12 HG12 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.241 0.639 0 CA-C-O 120.53 0.205 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 HD12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.41 ' HB3' HD21 ' A' ' 104' ' ' ASN . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 100' ' ' ASN . 8.9 m120 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 159' ' ' VAL . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.415 0.15 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.459 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -98.91 169.94 9.09 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.489 0.715 . . . . 0.0 111.108 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' ILE . 52.6 m -71.05 133.45 46.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.6 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 p -129.97 149.79 51.54 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.203 -172.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 154' ' ' THR . 31.8 tp -135.43 101.62 4.88 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 78.4 p -110.37 166.76 10.72 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.95 0.9 . . . . 0.0 109.852 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.25 148.39 38.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.649 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.5 p -55.66 -39.02 70.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.83 0.852 . . . . 0.0 111.63 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -153.96 142.11 20.39 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 108.737 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CE1' ' HD2' ' A' ' 155' ' ' PRO . 85.4 m-85 -99.83 19.07 16.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.299 0.64 . . . . 0.0 110.731 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -145.52 121.82 10.9 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.688 1.195 . . . . 0.0 108.506 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -133.08 120.57 21.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.091 0.956 . . . . 0.0 109.234 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.5 m -92.6 133.17 36.23 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 127' ' ' PRO . 83.5 mt -72.91 125.32 27.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.142 0.577 . . . . 0.0 110.779 -175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.75 21.56 18.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.034 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.56 159.65 15.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.921 0.488 . . . . 0.0 109.899 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.83 -26.77 59.94 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.557 0.743 . . . . 0.0 111.167 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.48 117.92 13.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.498 0.719 . . . . 0.0 110.814 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -98.02 163.63 12.68 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.472 0.709 . . . . 0.0 110.457 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -108.03 114.6 28.63 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 9.1 mt -97.16 137.6 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.82 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -95.06 113.54 25.25 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.08 0.952 . . . . 0.0 108.874 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -104.27 136.2 44.31 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -138.18 86.55 2.17 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.038 0.935 . . . . 0.0 109.124 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 59' ' ' SER . 2.0 mp -99.88 129.16 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.511 1.125 . . . . 0.0 109.329 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -90.12 -23.42 21.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.878 0.871 . . . . 0.0 110.176 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -64.19 140.76 58.9 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.08 106.59 3.31 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.35 151.95 5.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.97 -167.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -100.81 145.11 29.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.13 -8.11 7.65 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.904 1.736 . . . . 0.0 114.238 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 m -88.21 0.03 56.56 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.24 154.6 41.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.235 0.614 . . . . 0.0 110.6 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.411 ' HZ3' ' HA2' ' A' ' 145' ' ' GLY . 8.4 p90 -159.64 166.34 30.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.2 mt -109.35 124.39 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 166.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 133.77 11.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -102.26 103.71 14.21 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 28.9 m-85 -117.39 145.85 43.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.046 0.538 . . . . 0.0 109.84 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -73.17 133.0 43.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.198 0.599 . . . . 0.0 109.438 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.19 90.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 166.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -137.61 133.26 34.18 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.495 -172.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -78.54 90.41 4.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.56 -172.76 3.83 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.583 1.153 . . . . 0.0 108.187 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.2 m -43.28 118.42 2.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.493 1.117 . . . . 0.0 111.644 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.85 -3.73 6.22 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.758 2.305 . . . . 0.0 113.846 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.2 75.71 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.992 0.517 . . . . 0.0 110.597 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 36.16 66.96 0.34 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.545 1.538 . . . . 0.0 112.811 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -55.97 100.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.554 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.6 -153.19 0.48 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.211 -165.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -84.46 176.34 8.73 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.7 p -166.77 162.23 16.0 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.844 -0.535 . . . . 0.0 111.162 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 11.0 mmpt? -85.56 129.52 34.8 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.133 170.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -86.32 -163.63 0.92 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.303 1.041 . . . . 0.0 110.221 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -37.67 131.09 1.0 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.733 1.213 . . . . 0.0 113.721 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 122.2 -23.71 7.18 Favored Glycine 0 N--CA 1.465 0.611 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.233 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 121' ' ' ILE . 30.9 m -107.77 19.2 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.528 0.731 . . . . 0.0 110.764 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -79.57 49.86 1.07 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.972 1.309 . . . . 0.0 112.367 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.92 57.92 3.13 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.338 -171.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -115.68 127.34 55.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -57.05 -58.07 9.79 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.042 0.537 . . . . 0.0 111.298 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -135.4 135.59 40.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.529 0.332 . . . . 0.0 110.938 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.71 -168.04 37.32 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 146.2 30.71 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.611 0.705 . . . . 0.0 112.16 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 113' ' ' VAL . 42.8 mt -128.91 111.13 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -78.05 140.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.508 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.7 t90 -148.2 131.94 16.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.275 0.63 . . . . 0.0 110.236 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -82.32 119.28 23.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.975 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.8 mt -81.49 97.88 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.91 144.97 28.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.222 0.609 . . . . 0.0 110.354 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HB3' HD13 ' A' ' 70' ' ' LEU . 63.0 Cg_endo -69.68 84.08 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.605 2.203 . . . . 0.0 112.405 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.36 -159.62 15.82 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.39 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.03 -24.24 60.21 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.087 2.525 . . . . 0.0 112.869 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -78.07 -27.7 48.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.514 0.726 . . . . 0.0 111.018 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.3 m-85 -114.32 83.69 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.441 0.639 . . . . 0.0 110.31 -174.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.3 mmt -110.04 -26.2 9.84 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.634 1.174 . . . . 0.0 111.664 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.592 ' HB2' HG13 ' A' ' 136' ' ' ILE . 37.5 mt-10 -76.23 163.21 67.84 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 124.103 0.961 . . . . 0.0 111.325 -172.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.08 -26.12 37.13 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.097 1.864 . . . . 0.0 111.703 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -147.7 103.21 3.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.238 1.015 . . . . 0.0 108.719 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.592 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.6 mp -88.61 108.21 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.22 1.008 . . . . 0.0 109.906 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 156' ' ' CYS . 32.0 mmmt -83.69 107.87 16.4 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -118.45 171.8 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.817 0.447 . . . . 0.0 110.183 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.651 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 24.9 p -157.2 131.89 8.69 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.24 0.616 . . . . 0.0 109.678 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -83.84 140.95 31.69 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.651 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 99.0 mttt -140.38 104.0 4.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.354 0.662 . . . . 0.0 110.099 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.47 105.91 7.8 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.533 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 75.2 m-85 -93.6 133.77 36.58 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.273 0.629 . . . . 0.0 109.882 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -78.14 116.6 18.71 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.411 ' HA2' ' HZ3' ' A' ' 91' ' ' TRP . . . -49.43 -35.21 20.93 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 124.485 1.116 . . . . 0.0 115.699 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.62 112.32 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t 72.56 -3.18 2.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 60.2 40.4 97.24 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.64 122.07 26.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.75 0.82 . . . . 0.0 110.309 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.24 110.03 2.44 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-O 121.109 0.481 . . . . 0.0 110.196 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -93.29 -32.62 14.25 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.393 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.92 153.42 22.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.92 0.488 . . . . 0.0 110.816 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 141' ' ' LYS . 51.5 m -147.75 144.56 28.34 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 0.0 110.54 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.464 HG23 ' HG ' ' A' ' 61' ' ' LEU . 82.8 p -85.09 147.25 47.33 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.572 0.749 . . . . 0.0 109.394 169.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 66' ' ' TYR . 87.8 Cg_exo -49.43 157.48 2.14 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.822 2.348 . . . . 0.0 112.929 163.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 24.7 p -61.75 106.35 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.6 mt -83.25 120.2 34.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 110.412 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 74.2 m -84.21 100.52 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.062 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.03 106.74 16.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.31 137.32 32.43 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.96 98.94 49.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.868 0 C-N-CA 122.754 2.303 . . . . 0.0 111.007 178.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -105.91 161.4 14.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.225 0.61 . . . . 0.0 110.69 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.7 p -71.34 111.05 6.36 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.945 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 129.84 49.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.863 0.865 . . . . 0.0 110.606 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 142' ' ' TYR . 19.1 mt -91.71 128.71 37.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 164.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 p -135.06 149.75 50.15 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.854 0.861 . . . . 0.0 108.732 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 168.32 9.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 122.955 0.502 . . . . 0.0 110.43 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.6 p -72.46 -27.35 62.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.645 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -164.45 143.13 7.1 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.811 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' HD1' HG12 ' A' ' 157' ' ' ILE . 85.5 m-85 -100.63 23.64 10.13 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.97 0.508 . . . . 0.0 110.528 175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -137.47 139.45 40.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.76 0.824 . . . . 0.0 109.905 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 6.0 t80 -149.72 114.27 5.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -89.92 127.12 35.95 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 127' ' ' PRO . 3.5 mm? -57.04 139.68 51.5 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.123 0.42 . . . . 0.0 110.64 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.51 -5.61 67.46 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.584 -0.734 . . . . 0.0 113.539 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.03 146.23 26.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.384 0.592 . . . . 0.0 110.284 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.74 -36.82 67.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.152 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -54.62 103.6 0.09 Allowed 'General case' 0 N--CA 1.477 0.875 0 O-C-N 124.15 0.906 . . . . 0.0 111.352 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -74.08 165.51 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.236 1.014 . . . . 0.0 111.123 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 68' ' ' TYR . 5.2 tt -119.41 119.25 33.38 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -175.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mt -106.18 132.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.033 0.533 . . . . 0.0 109.944 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 154' ' ' THR . 46.6 mm -101.35 103.7 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.752 0.821 . . . . 0.0 109.395 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -86.74 111.7 20.95 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.214 1.006 . . . . 0.0 108.982 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 45.6 p90 -100.41 140.63 34.4 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -130.91 99.3 4.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.13 103.67 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -21.25 64.95 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.896 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.39 155.15 24.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.359 1.064 . . . . 0.0 110.43 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -56.66 134.04 54.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.422 1.089 . . . . 0.0 109.989 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 m -123.22 161.3 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.717 0.807 . . . . 0.0 110.12 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 115' ' ' GLY . 56.3 m-20 -111.89 164.45 15.12 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 124.383 1.073 . . . . 0.0 109.265 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.57 13.34 1.41 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.362 2.042 . . . . 0.0 112.675 168.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.495 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 21.0 m -106.91 -6.84 17.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.288 1.035 . . . . 0.0 111.768 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.06 162.51 19.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.655 0.782 . . . . 0.0 111.401 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -161.67 157.76 25.0 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.031 0.443 . . . . 0.0 111.699 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.82 114.89 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.16 138.52 13.93 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 3.9 tt -96.57 115.87 28.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -120.68 139.37 53.13 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.732 0.813 . . . . 0.0 109.139 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.497 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 17.2 t-80 -75.8 131.97 40.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.78 90.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 11.8 t70 -137.93 136.11 36.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.799 0.84 . . . . 0.0 109.228 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.81 88.77 3.43 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -151.23 179.41 8.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.398 1.079 . . . . 0.0 108.892 -170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.1 m -36.44 118.84 0.72 Allowed Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 125.389 1.476 . . . . 0.0 111.997 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.07 -21.49 27.57 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.421 2.747 . . . . 0.0 113.934 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.75 88.6 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.333 0.653 . . . . 0.0 111.216 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 41.57 59.94 2.29 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.087 1.355 . . . . 0.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -56.03 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.323 0.582 . . . . 0.0 110.059 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -139.88 -155.02 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.794 1.238 . . . . 0.0 108.363 -170.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 32.9 t70 -85.94 168.17 14.42 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.354 0.662 . . . . 0.0 111.23 -165.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -143.1 144.58 32.29 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.337 1.055 . . . . 0.0 108.276 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 9.0 mmpt? -86.45 178.86 6.98 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -173.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.8 -166.53 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.06 -164.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -53.93 135.64 42.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.469 1.108 . . . . 0.0 112.346 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 124.11 -9.55 8.41 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.401 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.69 25.54 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.278 0.631 . . . . 0.0 110.291 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.7 t -78.86 21.67 0.41 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.822 1.249 . . . . 0.0 112.597 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . 76.07 58.11 3.81 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 p -96.23 142.72 28.06 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.415 0.686 . . . . 0.0 109.644 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.74 -53.43 57.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.222 1.009 . . . . 0.0 111.485 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 80' ' ' TRP . 84.3 tttt -149.54 139.2 21.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 -159.06 21.0 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.167 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 19.5 pt20 -159.0 139.28 12.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.909 0.484 . . . . 0.0 111.209 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.34 114.71 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -75.67 137.23 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.702 170.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -147.92 120.49 8.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.821 0.848 . . . . 0.0 109.509 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.46 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 41.1 ttm105 -91.29 122.61 34.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.5 mt -83.53 135.38 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.214 0.606 . . . . 0.0 110.755 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.27 144.33 31.5 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.151 0.981 . . . . 0.0 109.963 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HB3' ' HG ' ' A' ' 70' ' ' LEU . 84.2 Cg_endo -78.02 77.77 3.82 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.283 2.655 . . . . 0.0 112.173 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.57 -161.15 36.28 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.971 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.41 -9.96 24.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.92 -24.53 35.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.21 1.004 . . . . 0.0 111.072 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.625 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.5 m-85 -122.43 83.84 2.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 -175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 69.0 mtm -117.64 -21.23 8.62 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.128 0.971 . . . . 0.0 111.703 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.603 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -72.57 165.47 51.27 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 123.641 0.776 . . . . 0.0 111.298 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -30.39 89.11 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.285 1.99 . . . . 0.0 111.62 167.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -154.29 116.28 4.24 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.285 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -103.77 108.26 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.527 1.131 . . . . 0.0 109.062 -177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -87.14 111.83 21.34 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -113.15 178.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.178 0.591 . . . . 0.0 109.803 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 29.1 p -157.28 162.14 39.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.424 0.69 . . . . 0.0 109.826 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.32 142.15 47.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.428 1.091 . . . . 0.0 108.066 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.3 mttt -135.09 108.17 7.66 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' H ' HD11 ' A' ' 61' ' ' LEU . 35.4 t80 -84.54 114.77 22.2 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.98 161.07 13.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.142 0.977 . . . . 0.0 110.105 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -95.51 144.82 25.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . -60.9 -46.12 95.18 Favored Glycine 0 C--N 1.341 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 113.36 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.29 131.44 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.6 m 72.23 -18.0 0.35 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.404 1.482 . . . . 0.0 114.057 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.72 76.77 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -168.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.06 118.88 21.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 111.392 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.87 117.18 4.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.778 0.831 . . . . 0.0 111.362 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.44 -39.94 12.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.172 0.589 . . . . 0.0 110.845 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.94 158.0 19.24 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.673 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.446 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.1 m -140.13 136.83 33.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.384 1.074 . . . . 0.0 109.279 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 78' ' ' ILE . 71.4 p -69.21 140.2 90.44 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.77 162.22 0.72 Allowed 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 122.98 2.454 . . . . 0.0 113.296 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 18.3 p -57.57 104.53 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.337 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HD1' ' A' ' 66' ' ' TYR . 76.6 mt -83.14 108.89 16.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.526 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 160' ' ' LYS . 86.5 m -73.8 99.21 3.13 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.297 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.05 99.44 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 158' ' ' THR . 49.1 mtmt -90.6 138.38 31.61 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 110.069 -170.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -131.6 91.46 34.05 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 C--N 1.377 2.05 0 C-N-CA 123.565 2.843 . . . . 0.0 111.393 179.323 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 m . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -102.12 178.01 4.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.185 0.517 . . . . 0.0 112.145 -170.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' HG13 ' A' ' 82' ' ' ILE . 27.0 m -58.11 141.4 50.33 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.375 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 m -147.5 126.41 12.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.063 0.545 . . . . 0.0 110.64 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 142' ' ' TYR . 57.0 mt -98.41 140.79 32.15 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -143.47 171.44 14.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.8 1.24 . . . . 0.0 109.706 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.5 32.65 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.306 0.642 . . . . 0.0 110.022 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p -59.92 -36.86 77.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.938 0.895 . . . . 0.0 110.803 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -154.39 150.35 27.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.859 1.264 . . . . 0.0 108.483 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.43 22.4 15.99 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.31 0.576 . . . . 0.0 110.503 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.03 148.6 52.23 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.397 1.079 . . . . 0.0 108.588 167.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -155.05 143.62 20.55 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.1 m -122.15 124.04 42.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.74 124.83 21.07 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.67 10.44 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.737 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -86.87 149.05 25.09 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.996 0.518 . . . . 0.0 110.67 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.17 -17.53 34.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.46 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -59.68 114.36 2.71 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -92.45 157.02 16.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.412 1.085 . . . . 0.0 112.556 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 125' ' ' ILE . 56.7 tp -101.13 113.23 26.06 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.199 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.4 mt -103.39 117.94 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.1 mm -92.19 107.52 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.906 0.882 . . . . 0.0 109.4 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -90.5 124.95 35.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.119 0.968 . . . . 0.0 108.843 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 44.9 p90 -113.73 138.95 49.52 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.316 0.507 . . . . 0.0 110.282 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.84 85.76 2.36 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.807 1.243 . . . . 0.0 108.434 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.8 mp -105.38 127.76 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -123.31 10.34 9.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.938 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.98 163.21 16.24 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.061 1.345 . . . . 0.0 108.021 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.07 144.11 57.36 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.2 m -140.42 -179.07 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.198 1.399 . . . . 0.0 109.246 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -146.14 154.82 50.69 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' THR . 38.5 Cg_endo -64.77 -4.7 9.06 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.693 2.262 . . . . 0.0 113.464 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 m -76.84 -38.12 54.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 0.0 111.886 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.574 ' HB3' ' HA ' ' A' ' 144' ' ' HIS . 1.8 p30 -82.82 171.03 14.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -161.56 169.32 21.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.055 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.09 132.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -112.25 155.75 16.03 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 119.642 -0.532 . . . . 0.0 111.942 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.8 tt -100.66 117.8 35.5 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.05 153.59 48.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.868 0.867 . . . . 0.0 110.108 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 41.8 t-80 -90.32 143.55 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.775 0.83 . . . . 0.0 109.942 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 mm -67.3 92.53 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -139.48 137.3 35.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.825 0.45 . . . . 0.0 110.371 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -78.06 91.17 4.25 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -148.69 177.56 9.4 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.078 0.951 . . . . 0.0 109.421 -166.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -37.49 122.58 0.92 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.212 1.405 . . . . 0.0 111.405 168.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.87 -6.28 7.4 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 123.005 2.47 . . . . 0.0 114.099 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.55 -36.44 44.67 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.427 0.691 . . . . 0.0 110.632 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 49.52 64.54 1.71 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.883 1.273 . . . . 0.0 111.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -53.89 100.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.358 0.599 . . . . 0.0 111.349 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -151.23 -156.52 0.72 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.117 1.367 . . . . 0.0 109.008 -169.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 31.8 t70 -86.33 167.0 15.17 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.152 0.581 . . . . 0.0 110.148 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.546 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 62.1 p -135.09 148.59 49.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.209 1.003 . . . . 0.0 109.282 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 5.6 mmpt? -84.82 178.72 7.52 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.63 171.56 12.31 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 113.693 -1.594 . . . . 0.0 111.008 -170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -62.43 155.02 26.54 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.853 0.861 . . . . 0.0 111.02 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.47 -13.26 27.97 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.683 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.89 18.4 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.791 1.236 . . . . 0.0 109.633 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' PRO . 42.5 p -80.3 50.67 1.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.189 1.795 . . . . 0.0 111.719 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.27 56.29 4.39 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 137.5 43.53 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.071 0.948 . . . . 0.0 109.105 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -65.94 -68.61 0.36 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.218 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 132.43 37.79 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.59 -161.08 24.37 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.53 0.519 . . . . 0.0 111.886 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.14 143.31 17.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.485 0.714 . . . . 0.0 110.125 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.1 mt -127.22 122.03 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.07 142.87 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.933 0.893 . . . . 0.0 110.337 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.476 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.1 t90 -156.91 124.79 5.49 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.662 0.785 . . . . 0.0 109.762 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.78 126.57 31.14 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.828 0.851 . . . . 0.0 108.905 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 76' ' ' LEU . 19.6 mt -81.29 116.23 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.46 148.67 35.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.971 0.908 . . . . 0.0 108.785 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.54 77.5 1.74 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.825 2.35 . . . . 0.0 111.086 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.36 -171.31 47.4 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.975 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.92 -14.66 39.14 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.759 2.306 . . . . 0.0 112.137 176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.63 -7.27 47.47 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 111.28 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HA ' HG12 ' A' ' 136' ' ' ILE . 71.4 m-85 -122.19 83.1 2.05 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 54.9 mtm -119.19 -27.19 5.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.342 1.057 . . . . 0.0 111.158 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.47 157.75 70.56 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.115 0.966 . . . . 0.0 111.214 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.99 -26.76 83.74 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.471 169.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -151.3 112.63 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.5 mp -89.7 153.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 173.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.48 114.33 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.3 pt -113.76 168.74 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.276 0.56 . . . . 0.0 111.04 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.4 p -158.21 125.49 5.03 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.83 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 90.9 m-85 -88.48 132.81 34.33 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.344 1.057 . . . . 0.0 108.86 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -127.36 111.89 14.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.124 0.57 . . . . 0.0 110.028 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.9 t80 -75.51 106.1 6.88 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 172.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 44.5 m-85 -96.57 167.21 11.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.38 1.072 . . . . 0.0 109.973 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 151' ' ' ARG . 49.0 t-80 -121.76 139.03 54.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.335 1.054 . . . . 0.0 108.547 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.83 -139.17 32.51 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.943 0.777 . . . . 0.0 111.692 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.6 mt -96.25 82.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.6 p 51.72 34.46 13.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.658 1.583 . . . . 0.0 113.123 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.29 -92.91 0.96 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.722 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . -78.98 110.62 14.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.196 0.598 . . . . 0.0 111.124 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -71.27 104.53 3.16 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.124 0.57 . . . . 0.0 109.659 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.625 ' HD3' ' HB2' ' A' ' 144' ' ' HIS . 22.4 mmm180 -73.02 -45.37 58.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.977 . . . . 0.0 110.88 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.69 166.43 22.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.645 0.378 . . . . 0.0 111.621 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 87.1 m -150.61 137.55 19.17 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.29 1.036 . . . . 0.0 110.632 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 61.3 p -71.43 150.51 93.96 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.577 . . . . 0.0 109.811 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -54.55 155.52 16.74 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.487 2.125 . . . . 0.0 112.438 163.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.9 p -59.11 108.14 0.64 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.998 1.319 . . . . 0.0 111.728 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.43 HD13 HD21 ' A' ' 76' ' ' LEU . 55.8 mt -86.25 108.95 18.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.031 0.932 . . . . 0.0 109.367 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 82.2 m -73.71 101.17 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.073 0.949 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 125' ' ' ILE . 21.9 t -100.52 99.37 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.145 0.978 . . . . 0.0 108.733 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -88.43 138.03 31.8 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 109.822 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -123.35 98.85 40.7 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.835 0.854 . . . . 0.0 109.169 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.375 1.961 0 C-N-CA 123.567 2.845 . . . . 0.0 110.767 170.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.01 -173.16 2.69 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.807 1.243 . . . . 0.0 110.11 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 m -46.57 115.4 1.03 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.485 1.114 . . . . 0.0 113.006 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 m -136.16 148.35 48.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.11 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.75 133.16 56.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.779 0.832 . . . . 0.0 109.19 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -132.3 170.42 15.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.74 0.816 . . . . 0.0 110.057 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.33 159.4 42.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 0.0 110.4 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -64.52 -31.09 72.15 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.195 0.598 . . . . 0.0 110.469 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -160.7 140.88 11.25 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 124.605 1.162 . . . . 0.0 109.289 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.65 19.96 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.532 0.733 . . . . 0.0 110.53 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.5 146.48 46.3 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.064 0.946 . . . . 0.0 108.451 168.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -153.33 145.95 24.21 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.7 m -120.62 123.68 43.41 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.5 mm? -58.13 120.93 9.5 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.156 0.435 . . . . 0.0 111.273 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.73 35.56 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.16 154.37 41.42 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.277 0.539 . . . . 0.0 110.888 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.73 -29.51 51.19 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.685 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -65.91 120.9 13.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.575 0.35 . . . . 0.0 110.92 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 32.8 m-80 -85.6 146.88 26.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.093 0.957 . . . . 0.0 110.582 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.5 tt -104.0 126.17 50.92 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.642 0.777 . . . . 0.0 109.154 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.01 127.33 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.696 0.798 . . . . 0.0 109.293 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 113.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.878 0.871 . . . . 0.0 109.394 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -97.13 151.71 19.52 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.368 1.067 . . . . 0.0 109.865 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -138.61 142.23 39.14 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.453 0.701 . . . . 0.0 110.608 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -138.61 89.0 2.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.165 . . . . 0.0 109.368 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.88 133.07 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.605 1.162 . . . . 0.0 108.619 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.33 -37.26 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.439 0.695 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.28 177.75 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.398 0.679 . . . . 0.0 111.715 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.43 135.91 57.35 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.519 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.55 164.78 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.202 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.37 139.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.98 4.92 0.33 Allowed 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.448 2.098 . . . . 0.0 115.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.0 m -99.48 -4.79 30.57 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.573 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 2.7 p30 -92.61 168.85 10.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 118.449 0.568 . . . . 0.0 112.088 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -157.08 165.0 37.29 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.564 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 113' ' ' VAL . 61.4 mt -98.67 134.56 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 164.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -113.29 144.43 18.1 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.162 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 6.0 tt -95.05 115.16 27.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -124.24 134.41 53.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.295 1.038 . . . . 0.0 108.58 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.08 136.15 43.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.17 91.42 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.81 143.83 39.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.689 0.796 . . . . 0.0 109.709 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.9 93.65 3.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB3' HD21 ' A' ' 104' ' ' ASN . 20.6 t-20 -152.75 176.27 11.96 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.173 0.989 . . . . 0.0 108.959 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -40.31 126.46 1.75 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 125.739 1.616 . . . . 0.0 112.815 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.02 -9.04 17.76 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.915 2.41 . . . . 0.0 112.879 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.89 69.26 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.489 0.716 . . . . 0.0 110.918 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 100' ' ' ASN . 12.7 m120 38.91 65.94 0.6 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.153 1.381 . . . . 0.0 112.621 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -56.61 102.06 0.07 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.268 0.556 . . . . 0.0 110.047 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.07 -157.2 0.79 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.899 1.28 . . . . 0.0 109.263 -167.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 38.9 t70 -87.72 173.0 9.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.334 0.654 . . . . 0.0 110.276 -170.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 50.9 p -140.74 167.57 21.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.303 0.641 . . . . 0.0 110.555 175.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -84.97 -179.52 7.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.134 0.974 . . . . 0.0 111.621 -177.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -82.98 175.77 9.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.961 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -71.25 153.08 42.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.558 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.71 -16.2 6.99 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 92' ' ' ILE . 11.0 t -101.54 30.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 124.899 1.28 . . . . 0.0 108.378 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -76.95 47.4 0.52 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.317 1.447 . . . . 0.0 111.778 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.92 4.97 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.1 p -110.99 126.75 55.11 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.273 1.029 . . . . 0.0 110.147 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -56.08 -58.29 8.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.761 0.824 . . . . 0.0 110.858 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -137.0 136.4 38.44 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.337 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.54 -166.2 34.88 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.565 0.541 . . . . 0.0 112.562 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.09 155.82 31.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 111.084 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.3 mt -136.57 116.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.272 1.029 . . . . 0.0 109.191 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.42 148.0 5.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.502 0.721 . . . . 0.0 109.708 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -163.8 132.74 3.84 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.973 0.909 . . . . 0.0 109.546 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 76.0 ttt180 -98.27 116.17 29.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.1 mt -80.06 120.67 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.15 145.88 30.77 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.662 0.785 . . . . 0.0 110.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.41 83.66 0.63 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.976 2.451 . . . . 0.0 112.027 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.11 -166.58 41.49 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.044 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.27 -15.84 43.05 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.894 2.396 . . . . 0.0 112.542 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.54 3.07 42.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.97 0.908 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 136' ' ' ILE . 87.1 m-85 -133.63 81.85 1.95 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 50.3 mtm -134.9 -17.26 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.681 0.793 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' HG13 ' A' ' 136' ' ' ILE . 39.3 mt-10 -64.33 161.08 44.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.36 0.664 . . . . 0.0 110.368 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.34 -29.03 89.15 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.964 1.776 . . . . 0.0 111.972 172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.89 107.63 3.18 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.095 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.7 mp -101.14 107.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.995 0.918 . . . . 0.0 109.095 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 123.62 34.12 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 136' ' ' ILE . 2.9 pp -127.13 171.34 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.365 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.0 p -154.14 138.62 16.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.268 0.627 . . . . 0.0 109.468 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -95.9 138.17 33.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 109.431 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -129.34 118.74 22.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.009 0.524 . . . . 0.0 110.887 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -83.19 123.88 29.99 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -107.59 166.72 10.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.556 1.142 . . . . 0.0 110.179 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -120.31 125.64 48.56 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.061 0.545 . . . . 0.0 109.918 173.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.573 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . 67.66 -175.3 26.69 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.706 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.6 tt -83.08 71.17 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-O 122.4 1.095 . . . . 0.0 108.989 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.5 t -161.58 174.92 12.66 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.599 -173.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.98 27.75 9.68 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.495 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.84 105.75 7.05 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.156 0.582 . . . . 0.0 109.431 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.3 tp -86.58 111.62 20.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.35 0.66 . . . . 0.0 110.341 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -78.01 -51.06 10.93 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.963 0.505 . . . . 0.0 110.462 173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.42 30.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.064 0.459 . . . . 0.0 111.833 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.6 m -141.95 139.6 32.53 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -71.83 142.79 86.07 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.042 0.537 . . . . 0.0 109.613 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.07 135.99 29.85 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.373 2.049 . . . . 0.0 111.429 161.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 28.2 p -50.41 118.6 3.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.474 1.11 . . . . 0.0 112.429 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.54 116.56 27.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.1 m -84.3 97.51 9.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.845 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.53 95.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.5 139.23 30.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 109.245 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 18.9 t30 -114.48 109.8 48.05 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.536 . . . . 0.0 110.148 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 CA--C 1.562 1.876 0 C-N-CA 122.979 2.453 . . . . 0.0 110.377 170.553 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 6.5 ppt_? -153.9 -177.94 6.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.138 0.975 . . . . 0.0 111.04 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.3 m -58.06 110.64 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.55 0.74 . . . . 0.0 110.907 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.2 m -108.51 147.8 31.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.251 0.62 . . . . 0.0 110.01 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.96 118.57 10.41 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -134.3 139.4 45.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.587 1.155 . . . . 0.0 108.642 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -99.39 160.78 14.03 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -62.81 -37.48 86.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.74 0.816 . . . . 0.0 109.581 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -157.64 143.22 17.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.208 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -101.23 17.61 22.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.45 0.7 . . . . 0.0 110.693 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -136.71 136.26 38.87 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 108.366 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -148.17 118.58 7.38 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.566 0.747 . . . . 0.0 109.374 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.4 m -92.27 128.47 38.13 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.225 0.61 . . . . 0.0 109.594 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 127' ' ' PRO . 95.6 mt -65.45 132.43 48.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.683 0.793 . . . . 0.0 111.359 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.88 13.54 69.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.982 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -88.54 160.39 17.48 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 117.724 0.762 . . . . 0.0 110.002 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.37 -18.89 54.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.39 0.676 . . . . 0.0 111.734 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.6 109.1 12.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.37 0.668 . . . . 0.0 109.298 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -85.55 150.75 24.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.675 0.79 . . . . 0.0 110.473 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 tt -101.37 115.6 30.87 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.2 mt -99.76 134.06 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.993 0.517 . . . . 0.0 109.798 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 46.3 mm -107.9 110.16 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -100.17 136.62 39.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.517 1.127 . . . . 0.0 109.717 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.88 141.43 42.77 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -131.17 89.43 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.94 1.296 . . . . 0.0 108.972 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.8 mt -108.51 126.84 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.779 1.232 . . . . 0.0 109.882 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -98.08 -8.57 27.45 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.062 0.545 . . . . 0.0 110.911 176.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -78.74 171.67 14.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.852 1.261 . . . . 0.0 111.554 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -73.0 103.95 3.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 ' OE1' ' A' ' 117' ' ' GLN . 19.6 m -94.52 144.88 8.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 109.434 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -133.15 155.35 81.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.198 0.999 . . . . 0.0 109.267 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.51 -2.36 6.06 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.404 2.069 . . . . 0.0 115.008 -171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.8 t -88.7 -19.28 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.344 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 5.1 p30 -71.31 162.72 28.97 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.435 0.561 . . . . 0.0 112.246 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -161.94 162.99 29.3 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.752 0.658 . . . . 0.0 110.848 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 113' ' ' VAL . 56.0 mt -98.42 133.6 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 165.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -110.63 134.79 12.41 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 tt -96.22 112.55 24.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HE2' ' HE1' ' A' ' 143' ' ' TYR . 73.9 m-85 -125.82 141.72 51.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.571 0.748 . . . . 0.0 110.885 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.419 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 42.9 t-80 -91.78 122.64 34.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.934 0.893 . . . . 0.0 110.25 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.25 90.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.101 0.961 . . . . 0.0 109.372 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.419 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 36.8 t70 -140.06 156.1 46.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.991 0.916 . . . . 0.0 109.609 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -76.09 93.2 3.28 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 171.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.12 -170.1 3.16 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.713 0.805 . . . . 0.0 109.034 -171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.1 m -37.69 124.76 0.96 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 125.955 1.702 . . . . 0.0 113.91 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.11 -20.96 71.57 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.156 2.571 . . . . 0.0 112.46 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.57 -35.17 53.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.415 0.686 . . . . 0.0 110.691 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 44.1 67.11 0.72 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.681 1.592 . . . . 0.0 111.484 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -56.6 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.497 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.7 -155.98 0.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 0.0 109.196 -171.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.9 t70 -83.56 165.46 19.05 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.856 0.463 . . . . 0.0 110.293 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 68.1 m -143.85 148.21 35.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.177 0.991 . . . . 0.0 109.241 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.1 mmpt? -84.19 164.39 19.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.882 0.849 . . . . 0.0 112.381 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -93.79 -166.89 1.59 Allowed 'General case' 0 C--O 1.243 0.763 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.453 -164.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -60.75 150.66 31.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.323 1.049 . . . . 0.0 112.019 -175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.1 -20.33 23.93 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.84 -166.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 92' ' ' ILE . 5.9 t -105.45 28.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 124.754 1.222 . . . . 0.0 108.921 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.9 p -82.53 48.06 1.25 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.605 1.162 . . . . 0.0 112.174 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.79 53.33 5.42 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.9 p -102.47 122.59 44.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.639 0.776 . . . . 0.0 109.831 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.424 ' OE1' HG22 ' A' ' 86' ' ' VAL . 13.1 mm100 -55.66 -50.74 69.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.689 0.796 . . . . 0.0 110.098 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -139.47 138.52 36.49 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.01 175.09 47.06 Favored Glycine 0 CA--C 1.507 -0.414 0 O-C-N 123.686 0.616 . . . . 0.0 112.467 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.74 135.42 23.34 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.661 0.784 . . . . 0.0 110.237 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.59 118.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.77 133.95 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -147.18 126.11 12.77 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.349 0.659 . . . . 0.0 109.304 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -88.13 114.5 24.81 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 mt -80.66 122.37 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.98 156.67 65.47 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 37.0 Cg_endo -62.37 92.59 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.761 2.308 . . . . 0.0 112.387 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.78 -158.92 33.36 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.941 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.09 -7.87 19.46 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 0.0 111.401 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -101.01 -16.95 16.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.574 1.149 . . . . 0.0 111.27 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.647 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.6 m-85 -126.49 83.67 2.19 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.037 0.535 . . . . 0.0 109.643 -172.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 59.6 mtm -130.47 -15.82 3.54 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.841 0.856 . . . . 0.0 111.419 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.1 mt-10 -74.9 162.15 74.66 Favored Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 124.322 1.049 . . . . 0.0 110.381 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.61 -25.92 54.31 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.358 2.039 . . . . 0.0 111.713 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -149.0 105.0 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.965 0.906 . . . . 0.0 108.809 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.3 mp -95.33 108.35 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.448 1.099 . . . . 0.0 109.073 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.56 108.45 17.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -125.27 172.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.655 0.662 . . . . 0.0 110.924 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 26.7 p -155.91 143.23 19.27 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.427 0.691 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -96.72 126.9 42.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.107 0.963 . . . . 0.0 109.68 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 153' ' ' THR . 91.4 mttt -126.63 106.85 9.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.638 0.775 . . . . 0.0 110.337 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.83 103.05 7.53 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.525 ' HE1' ' HE2' ' A' ' 95' ' ' TYR . 90.6 m-85 -87.04 154.22 20.93 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 0.0 109.674 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -81.07 160.59 24.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 109.035 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.55 -30.48 65.34 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.543 0.527 . . . . 0.0 113.995 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.44 98.01 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.8 p -60.45 110.3 1.23 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.136 0.974 . . . . 0.0 111.52 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.8 -36.51 2.62 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.44 111.41 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.414 0.686 . . . . 0.0 110.264 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.1 tp -95.44 122.8 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.678 0.791 . . . . 0.0 109.731 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -90.58 -46.13 8.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.88 0.472 . . . . 0.0 111.809 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -150.78 154.8 38.0 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.839 0.456 . . . . 0.0 111.094 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.1 m -151.48 138.93 19.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.408 1.083 . . . . 0.0 109.779 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 63.6 p -88.57 154.61 50.94 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.498 0.719 . . . . 0.0 109.374 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.11 177.91 2.78 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.229 1.953 . . . . 0.0 112.43 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.3 p -64.78 103.79 0.75 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.928 0.891 . . . . 0.0 111.152 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.3 mt -83.51 113.11 22.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.434 1.094 . . . . 0.0 109.284 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 62.2 m -76.33 101.31 5.45 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.306 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.76 105.99 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -90.0 139.68 30.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.048 0.939 . . . . 0.0 109.26 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -121.94 107.52 35.52 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.381 0.673 . . . . 0.0 109.703 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.374 1.916 0 C-N-CA 123.164 2.576 . . . . 0.0 111.984 168.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.16 147.69 35.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.324 0.65 . . . . 0.0 109.628 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.7 m -64.82 112.6 3.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 0.0 111.535 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -139.1 146.7 41.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.968 0.907 . . . . 0.0 110.674 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 mt -116.47 136.41 53.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.32 0.648 . . . . 0.0 109.452 170.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.1 p -136.79 167.9 20.57 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.907 1.283 . . . . 0.0 109.145 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -140.21 153.47 46.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.157 0.583 . . . . 0.0 110.396 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -62.61 -32.78 73.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.394 0.678 . . . . 0.0 110.429 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -155.32 146.95 23.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.326 1.051 . . . . 0.0 108.957 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -106.09 23.81 13.43 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -143.4 144.69 32.15 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.96 1.304 . . . . 0.0 108.516 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 3.0 t80 -154.57 127.99 8.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.701 0.8 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.5 m -106.06 131.98 52.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.279 0.632 . . . . 0.0 110.295 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.08 112.77 3.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.704 0.402 . . . . 0.0 110.367 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.86 -0.96 12.01 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.944 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -88.9 152.5 21.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.249 0.525 . . . . 0.0 110.763 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.0 -26.26 36.6 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.601 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.11 109.22 1.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.544 0.738 . . . . 0.0 110.059 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.04 154.38 19.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.587 0.755 . . . . 0.0 110.412 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 ' HB1' ' A' ' 63' ' ' ALA . 2.1 tt -100.65 118.15 36.21 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.348 0.659 . . . . 0.0 109.35 -170.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.02 122.09 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 122.819 0.448 . . . . 0.0 110.027 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.4 mm -96.35 112.13 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.393 1.077 . . . . 0.0 108.879 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -97.21 125.68 41.9 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.473 ' HH2' HG13 ' A' ' 121' ' ' ILE . 47.6 p90 -119.62 149.56 41.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 111.05 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.8 t70 -134.01 100.71 4.81 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.46 107.74 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -23.58 65.11 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.124 0.97 . . . . 0.0 112.09 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.36 139.89 37.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.622 0.769 . . . . 0.0 109.363 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.7 119.2 8.23 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.029 0.83 . . . . 0.0 110.022 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 115' ' ' GLY . 26.8 m -110.21 -177.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.764 0.826 . . . . 0.0 110.288 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.13 165.89 17.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.12 0.968 . . . . 0.0 109.572 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.35 -1.47 6.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.438 2.092 . . . . 0.0 112.915 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m -66.3 -45.64 79.71 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.815 0.846 . . . . 0.0 110.574 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.692 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 1.4 p30 -86.2 164.67 17.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.143 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.88 164.62 36.72 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.913 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.88 124.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.75 128.56 9.11 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 7.3 tt -86.52 105.79 17.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 104' ' ' ASN . 23.4 m-85 -107.08 152.91 23.39 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.74 1.216 . . . . 0.0 109.775 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.08 131.84 37.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.633 0.773 . . . . 0.0 109.752 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.423 HD11 ' SG ' ' A' ' 139' ' ' CYS . 45.3 mm -75.3 89.76 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.577 0.751 . . . . 0.0 109.687 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.0 154.31 45.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.218 1.007 . . . . 0.0 108.489 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.97 91.38 4.21 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.23 -171.74 3.92 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.912 -167.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 m -40.73 125.96 1.91 Allowed Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 126.016 1.726 . . . . 0.0 113.911 174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.38 -21.36 41.04 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.465 2.11 . . . . 0.0 112.784 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.58 62.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.675 0.39 . . . . 0.0 111.009 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HB3' ' HD2' ' A' ' 95' ' ' TYR . 4.1 t-20 33.72 66.9 0.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.346 1.858 . . . . 0.0 112.978 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -53.94 102.53 0.06 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.33 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -153.16 0.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.638 1.575 . . . . 0.0 107.667 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.0 t70 -82.97 155.76 23.82 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.382 0.537 . . . . 0.0 109.762 -167.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.1 p -120.62 148.97 43.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.879 0.872 . . . . 0.0 108.731 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.577 ' HA ' ' NZ ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -85.0 165.62 17.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.144 0.973 . . . . 0.0 113.089 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.53 -169.16 2.51 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 112.539 -2.119 . . . . 0.0 111.106 -162.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -59.23 144.87 44.84 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.573 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.11 -20.74 6.26 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-O 119.735 -0.48 . . . . 0.0 112.086 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.99 25.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.411 1.1 . . . . 0.0 108.47 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.7 p -84.21 47.39 1.32 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.576 1.151 . . . . 0.0 111.545 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . 79.49 57.67 3.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.372 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 p -117.78 131.35 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.962 0.905 . . . . 0.0 109.629 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 86' ' ' VAL . 21.0 mm-40 -67.55 -65.24 0.71 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.247 0.619 . . . . 0.0 110.193 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -126.55 133.03 51.2 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.46 -159.47 19.02 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.298 0.374 . . . . 0.0 112.369 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 18.5 pt20 -157.87 134.85 10.0 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 0.0 111.233 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.9 mt -111.63 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.74 132.86 31.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 166.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.552 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 36.3 t90 -150.16 117.84 6.18 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.908 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -68.01 122.79 18.97 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.389 167.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.552 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 10.0 mt -79.79 104.45 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.995 -1.484 . . . . 0.0 106.995 169.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -91.36 147.47 35.5 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.44 82.21 1.16 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.607 2.205 . . . . 0.0 112.374 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.69 -173.07 49.36 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.26 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.69 -17.69 42.54 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.536 2.157 . . . . 0.0 111.946 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -77.58 -22.6 50.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.234 1.014 . . . . 0.0 111.39 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' HA ' HG12 ' A' ' 136' ' ' ILE . 51.5 m-85 -116.47 82.01 1.72 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 46.9 mtm -132.73 -5.82 3.21 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.845 0.858 . . . . 0.0 111.127 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 36.9 mt-10 -78.68 162.59 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.934 0.894 . . . . 0.0 108.871 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.59 -36.84 73.84 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.471 1.447 . . . . 0.0 110.322 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 160' ' ' LYS . 13.4 mp0 -137.95 132.07 31.81 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.9 mp -116.97 106.42 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.03 117.61 24.1 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 136' ' ' ILE . 2.8 pp -130.66 143.83 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.145 0.578 . . . . 0.0 110.563 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 28.1 p -130.05 136.96 49.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 109.429 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -88.68 134.74 33.81 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.039 0.936 . . . . 0.0 109.67 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.525 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 97.1 mttt -129.06 104.06 7.35 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.456 0.702 . . . . 0.0 109.912 -174.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -76.25 118.61 19.15 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.5 m-85 -100.46 165.21 11.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.653 0.781 . . . . 0.0 109.137 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -127.47 109.7 12.01 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.692 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . 91.08 159.25 35.47 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 123.666 0.604 . . . . 0.0 112.568 -175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.2 mm -68.56 109.84 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.035 0.934 . . . . 0.0 109.625 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.2 m 63.69 21.52 12.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.546 1.139 . . . . 0.0 111.24 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.23 -172.65 44.96 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.46 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 146.73 53.13 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.676 0.79 . . . . 0.0 111.813 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.2 tp -68.07 108.21 3.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.297 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -74.73 -41.21 60.58 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.458 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.99 165.56 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.959 0.904 . . . . 0.0 110.689 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.403 HG23 ' HG2' ' A' ' 141' ' ' LYS . 35.1 m -147.94 145.07 28.45 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.859 0.864 . . . . 0.0 110.73 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 48.9 p -87.61 156.1 53.37 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.463 0.705 . . . . 0.0 109.813 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.61 163.48 1.84 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.29 2.66 . . . . 0.0 114.22 164.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.7 p -70.01 106.31 3.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.425 1.09 . . . . 0.0 110.414 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.2 mt -84.98 122.48 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.388 1.075 . . . . 0.0 110.28 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 25.8 m -83.99 104.27 13.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.132 0.973 . . . . 0.0 111.057 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 43.6 t -93.91 109.23 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.075 0.55 . . . . 0.0 109.533 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 135' ' ' GLU . 66.9 mmtt -90.38 127.1 36.09 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.539 0.736 . . . . 0.0 109.813 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 3.5 t-20 -122.08 90.13 48.75 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 123.432 0.693 . . . . 0.0 109.734 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.377 2.041 0 C-N-CA 123.47 2.78 . . . . 0.0 110.987 174.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -124.68 168.06 13.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.247 0.619 . . . . 0.0 111.602 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 31.0 p -105.85 110.16 22.36 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.09 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -142.2 160.4 40.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.214 0.53 . . . . 0.0 111.7 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 142' ' ' TYR . 36.4 mt -114.46 137.13 52.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.453 1.101 . . . . 0.0 109.345 169.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -134.81 170.24 16.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.936 0.895 . . . . 0.0 109.478 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -141.9 151.57 42.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.231 0.613 . . . . 0.0 110.359 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.7 p -60.18 -36.76 78.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.64 0.776 . . . . 0.0 110.938 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -152.0 139.97 20.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.649 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -98.71 22.99 9.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.368 0.667 . . . . 0.0 110.077 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 160' ' ' LYS . 38.5 mt-10 -143.09 125.13 15.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 108.759 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.528 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 18.3 t80 -132.52 117.35 17.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.965 0.506 . . . . 0.0 109.914 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 m -88.92 122.19 32.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.181 0.592 . . . . 0.0 109.574 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.73 118.87 10.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.902 0.481 . . . . 0.0 110.48 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.6 -6.72 16.1 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.287 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.76 160.86 22.21 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.993 0.425 . . . . 0.0 110.999 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.21 53.09 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.856 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.61 110.12 3.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.489 0.716 . . . . 0.0 110.485 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -84.49 162.75 19.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.086 0.554 . . . . 0.0 110.134 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.7 tt -104.43 115.93 31.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 109.458 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 20.5 mt -92.47 123.41 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.029 0.532 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.7 mm -99.09 114.3 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.728 0.811 . . . . 0.0 109.282 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.93 149.15 21.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.32 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.474 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.1 p90 -141.39 142.24 33.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' SER . 8.2 p-10 -136.44 106.44 6.3 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.9 103.42 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -21.14 65.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.547 1.139 . . . . 0.0 112.388 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.46 163.0 13.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.358 1.063 . . . . 0.0 109.93 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 138.3 53.98 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.358 1.063 . . . . 0.0 111.692 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.85 149.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.395 1.078 . . . . 0.0 109.525 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 46.1 m-20 -88.82 155.54 50.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -14.54 44.47 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.139 1.893 . . . . 0.0 112.937 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 13.98 33.25 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.712 0.805 . . . . 0.0 112.019 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.92 149.24 41.11 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.06 0.544 . . . . 0.0 110.504 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -156.16 149.96 25.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.615 HG13 HG11 ' A' ' 113' ' ' VAL . 76.5 mt -98.7 125.66 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.66 128.62 9.52 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.9 tt -84.84 105.4 15.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 104' ' ' ASN . 3.2 m-85 -105.07 157.93 16.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.315 1.046 . . . . 0.0 109.761 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -92.44 140.92 29.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.58 0.752 . . . . 0.0 109.759 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 139' ' ' CYS . 46.0 mm -78.03 89.63 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.338 0.59 . . . . 0.0 109.886 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.05 148.7 38.88 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.558 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.05 91.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -140.08 -176.05 4.46 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.44 -164.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 m -44.39 123.13 4.42 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.357 1.063 . . . . 0.0 111.903 164.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.2 -31.43 93.43 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.683 2.255 . . . . 0.0 112.618 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.29 82.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 95' ' ' TYR . 13.7 t-20 32.76 65.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 126.257 1.823 . . . . 0.0 112.569 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -56.11 100.59 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.404 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -141.51 -154.77 0.54 Allowed 'General case' 0 C--O 1.244 0.798 0 C-N-CA 125.532 1.533 . . . . 0.0 108.206 -170.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 19.1 t70 -83.4 166.67 18.2 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.1 p -145.55 153.19 40.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.005 0.522 . . . . 0.0 109.897 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -85.76 154.42 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.456 0.646 . . . . 0.0 111.733 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -86.07 -165.61 1.3 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.362 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -52.59 146.21 10.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.547 1.139 . . . . 0.0 112.019 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.36 -21.3 10.05 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HG13 ' A' ' 92' ' ' ILE . 6.5 t -109.32 22.71 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 124.157 0.983 . . . . 0.0 108.874 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -80.92 50.73 1.42 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.96 1.304 . . . . 0.0 111.209 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.68 3.02 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.608 -171.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.7 p -112.33 127.91 56.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.257 1.023 . . . . 0.0 109.57 174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.1 -54.67 19.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.035 0.534 . . . . 0.0 110.673 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -141.78 127.16 18.76 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.753 0.421 . . . . 0.0 110.226 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.56 -162.27 24.43 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.335 0.397 . . . . 0.0 112.522 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.93 151.7 29.74 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.585 0.354 . . . . 0.0 110.39 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.474 HG13 ' HH2' ' A' ' 80' ' ' TRP . 55.5 mt -130.54 118.72 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.4 p -81.41 131.29 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 30.9 t90 -143.7 128.84 18.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.526 0.73 . . . . 0.0 109.996 -174.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.528 ' HG3' ' OH ' ' A' ' 68' ' ' TYR . 54.5 ttp180 -85.34 123.75 31.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.422 0.689 . . . . 0.0 109.371 172.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 6.3 mt -79.51 121.6 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -117.19 140.57 27.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.513 0.725 . . . . 0.0 109.118 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 40.7 Cg_endo -64.66 86.58 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.903 2.402 . . . . 0.0 112.499 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.45 -159.43 27.99 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.036 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.18 -21.09 42.68 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.683 2.256 . . . . 0.0 112.477 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.31 -11.35 38.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.953 0.901 . . . . 0.0 111.343 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 136' ' ' ILE . 77.0 m-85 -128.11 82.72 2.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 80.7 mtp -124.35 -27.96 3.71 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.032 0.933 . . . . 0.0 111.17 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.686 ' HB2' HG13 ' A' ' 136' ' ' ILE . 34.7 mt-10 -58.56 152.77 43.74 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.369 1.068 . . . . 0.0 111.169 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.87 -18.96 63.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.357 2.038 . . . . 0.0 111.939 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -156.4 119.05 4.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.795 0.838 . . . . 0.0 108.772 171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.686 HG13 ' HB2' ' A' ' 133' ' ' GLU . 2.5 mp -105.55 113.36 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.873 0.869 . . . . 0.0 109.488 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -85.41 120.97 27.47 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.9 pt -130.91 179.52 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.247 0.619 . . . . 0.0 111.061 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.558 ' HB3' HD11 ' A' ' 97' ' ' ILE . 25.8 p -162.61 173.25 14.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.05 1.34 . . . . 0.0 108.751 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.39 141.72 51.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.246 1.018 . . . . 0.0 108.529 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.93 103.4 5.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.216 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.425 ' HB2' HD21 ' A' ' 61' ' ' LEU . 31.7 t80 -73.97 100.43 3.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.594 0.758 . . . . 0.0 108.977 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -88.74 157.29 18.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.839 0.856 . . . . 0.0 110.491 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.14 167.08 11.59 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 87' ' ' ASP . . . -63.92 -32.75 85.23 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.13 107.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.411 0.624 . . . . 0.0 109.538 163.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -56.71 128.04 34.51 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.137 1.375 . . . . 0.0 112.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.41 -13.04 68.06 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.878 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.99 108.27 16.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.704 0.252 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -86.9 128.22 35.05 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.972 0.509 . . . . 0.0 109.914 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.45 -40.37 6.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.186 0.594 . . . . 0.0 111.343 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.36 159.37 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.578 0.351 . . . . 0.0 111.798 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.0 m -147.7 136.22 21.7 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.9 0.88 . . . . 0.0 110.921 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 77.6 p -73.96 148.31 86.84 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.16 0.584 . . . . 0.0 110.401 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.58 162.05 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.564 2.843 . . . . 0.0 114.338 163.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.08 107.37 1.89 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.452 1.101 . . . . 0.0 111.39 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.14 118.16 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.354 1.062 . . . . 0.0 110.981 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.4 m -85.45 102.33 13.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.995 0.918 . . . . 0.0 110.116 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.94 118.9 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -92.31 141.96 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.34 83.64 49.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.075 0 C-N-CA 123.358 2.705 . . . . 0.0 111.185 177.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -88.73 179.33 6.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.726 0.81 . . . . 0.0 111.797 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -65.59 135.52 55.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.171 0.988 . . . . 0.0 111.773 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 p -118.02 149.89 40.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.346 0.659 . . . . 0.0 111.168 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 14.1 tp -134.73 106.79 7.1 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.4 p -113.2 168.09 10.01 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 110.147 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.03 46.58 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.791 0.836 . . . . 0.0 108.85 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 p -59.9 -40.18 87.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.571 0.748 . . . . 0.0 111.742 -175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -152.46 133.96 14.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.945 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -97.09 10.08 40.33 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.4 0.68 . . . . 0.0 110.919 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.94 150.68 40.73 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -163.05 146.65 10.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.051 . . . . 0.0 108.75 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 31.3 m -133.42 134.98 44.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.9 121.39 15.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.29 -22.06 7.58 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.314 -165.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' THR . 37.2 tt0 -79.93 123.16 27.53 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.646 1.179 . . . . 0.0 109.356 173.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.93 -15.35 48.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.66 0.784 . . . . 0.0 111.886 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -62.58 125.41 23.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.77 0.428 . . . . 0.0 110.323 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -76.28 151.16 36.83 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.627 0.771 . . . . 0.0 111.434 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 125' ' ' ILE . 6.4 tt -108.68 133.65 52.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 mt -121.66 138.19 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.9 mm -105.74 112.39 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.43 130.76 50.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.149 0.98 . . . . 0.0 108.835 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 61' ' ' LEU . 42.6 p90 -127.94 147.3 50.47 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.02 0.438 . . . . 0.0 110.157 173.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.56 96.8 3.41 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.209 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.25 112.99 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.501 1.12 . . . . 0.0 108.79 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -95.12 -8.23 37.08 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.232 0.613 . . . . 0.0 111.373 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.86 155.57 25.28 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -52.35 108.36 0.29 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.42 1.088 . . . . 0.0 110.964 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 m -80.28 170.91 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.633 0.773 . . . . 0.0 111.69 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -127.0 132.52 24.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 124.178 0.991 . . . . 0.0 108.526 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.15 -11.72 32.88 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.226 1.951 . . . . 0.0 113.732 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 m -107.71 0.13 22.18 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.62 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.472 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.9 p30 -78.31 174.94 10.7 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.233 0.47 . . . . 0.0 111.285 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -152.29 153.72 34.27 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 121.734 0.778 . . . . 0.0 112.788 -169.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG13 HG11 ' A' ' 113' ' ' VAL . 87.4 mt -100.69 134.99 38.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 158.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -123.72 154.52 17.53 Favored Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 4.0 tt -93.12 112.48 24.45 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -120.83 149.82 41.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.402 1.081 . . . . 0.0 109.151 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 39.1 t-80 -94.27 131.96 39.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.356 0.663 . . . . 0.0 110.791 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -72.36 90.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.961 0.904 . . . . 0.0 109.268 173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.08 150.27 42.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.348 1.059 . . . . 0.0 109.211 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.03 92.18 1.29 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -151.92 179.05 8.8 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.953 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.6 m -44.31 123.28 4.37 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.796 1.238 . . . . 0.0 112.34 173.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.89 -14.26 42.12 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.92 2.414 . . . . 0.0 113.246 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.47 -37.05 74.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.443 0.697 . . . . 0.0 110.973 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.5 m120 38.0 65.82 0.54 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.063 1.345 . . . . 0.0 112.806 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -54.96 103.23 0.08 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -149.08 -155.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.946 1.298 . . . . 0.0 108.832 -165.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 29.6 t70 -84.86 158.01 20.75 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.61 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.1 p -138.79 154.66 48.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.628 0.771 . . . . 0.0 109.519 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -87.08 159.73 18.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.142 0.577 . . . . 0.0 111.006 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -85.45 -167.75 1.96 Allowed 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.706 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -57.6 145.44 33.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.332 1.053 . . . . 0.0 111.347 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -22.15 6.21 Favored Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 92' ' ' ILE . 10.7 t -102.27 28.33 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.514 1.126 . . . . 0.0 108.23 170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -80.13 47.73 0.93 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.258 1.423 . . . . 0.0 111.206 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.56 58.7 3.76 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.418 -0.356 . . . . 0.0 112.276 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -105.7 128.01 53.42 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.944 0.898 . . . . 0.0 110.922 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.946 0.898 . . . . 0.0 110.436 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -140.55 139.91 35.1 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.83 174.77 47.09 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.81 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -149.71 146.4 27.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.382 0.673 . . . . 0.0 110.605 174.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.4 mt -129.8 120.77 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.67 146.68 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.662 0.785 . . . . 0.0 110.091 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.429 ' HE1' HD22 ' A' ' 76' ' ' LEU . 7.1 p-90 -159.65 138.2 10.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.455 1.102 . . . . 0.0 108.348 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -102.07 127.43 48.97 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 76' ' ' LEU . 9.2 mt -79.8 116.66 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.76 150.51 37.08 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.815 0.846 . . . . 0.0 109.251 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.99 86.13 0.62 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.406 2.071 . . . . 0.0 111.258 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.17 -174.58 49.87 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.31 -23.59 44.55 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.488 2.125 . . . . 0.0 111.03 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.422 ' HB3' ' CH2' ' A' ' 106' ' ' TRP . 97.6 m-85 -81.66 -17.99 46.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.539 1.136 . . . . 0.0 111.356 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -121.36 80.59 1.68 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -132.26 -4.32 3.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.953 0.901 . . . . 0.0 111.092 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.521 ' HB2' HG12 ' A' ' 136' ' ' ILE . 29.1 mt-10 -78.12 147.8 73.76 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.68 -0.676 . . . . 0.0 109.356 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.31 -25.23 79.72 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.621 ' HG2' ' HG2' ' A' ' 160' ' ' LYS . 0.8 OUTLIER -156.07 114.39 3.38 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 138' ' ' ILE . 17.6 mt -113.77 128.05 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 109.525 -167.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -102.71 108.43 19.68 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 136' ' ' ILE . 2.7 pp -115.2 175.87 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.1 p -161.3 172.85 15.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.348 0.659 . . . . 0.0 109.276 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.98 145.49 48.07 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.87 0.868 . . . . 0.0 108.727 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.38 107.43 5.72 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.594 0.559 . . . . 0.0 110.414 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -76.85 101.14 5.77 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 94.1 m-85 -90.64 131.25 36.45 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 168.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -90.37 143.22 26.97 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.366 0.667 . . . . 0.0 110.069 -175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 90' ' ' ASP . . . -78.16 -57.1 3.52 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.249 0.343 . . . . 0.0 112.414 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.51 103.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.5 t 67.35 112.36 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 O-C-N 124.194 0.934 . . . . 0.0 108.901 -167.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.69 48.32 3.67 Favored Glycine 0 C--N 1.353 1.495 0 C-N-CA 123.351 0.501 . . . . 0.0 114.324 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.11 145.33 24.77 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.763 0.825 . . . . 0.0 110.538 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.3 103.13 1.19 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.23 -33.08 22.3 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.6 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -155.08 150.55 27.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.485 0.129 . . . . 0.0 111.304 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.9 m -148.15 140.45 24.26 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.125 0.97 . . . . 0.0 110.187 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 61' ' ' LEU . 69.5 p -79.6 148.89 70.52 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.086 0.554 . . . . 0.0 109.748 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -47.26 158.73 0.5 Allowed 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 123.294 2.663 . . . . 0.0 113.605 162.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.97 105.5 0.69 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.0 0.92 . . . . 0.0 110.971 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.27 113.65 21.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.25 1.02 . . . . 0.0 109.822 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.9 m -73.81 102.48 4.05 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.544 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.28 99.64 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.621 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 53.7 mtmt -91.23 133.47 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.458 0.703 . . . . 0.0 109.896 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -116.85 92.14 37.6 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.381 2.26 0 C-N-CA 123.732 2.955 . . . . 0.0 112.97 -177.521 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.57 179.77 5.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.372 0.669 . . . . 0.0 111.113 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.0 m -59.46 111.53 1.43 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.862 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 21.1 m -115.28 144.72 43.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.01 0.924 . . . . 0.0 110.327 -172.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.2 mt -123.1 129.14 51.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.86 0.864 . . . . 0.0 108.918 168.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.7 164.71 29.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.947 1.299 . . . . 0.0 109.471 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -132.66 152.03 51.8 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.605 0.762 . . . . 0.0 109.654 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.4 p -60.59 -30.29 69.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.516 0.726 . . . . 0.0 110.805 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.413 ' HE3' ' HD2' ' A' ' 68' ' ' TYR . 15.1 ptt? -158.16 134.76 9.63 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.32 1.048 . . . . 0.0 108.959 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -95.5 11.25 33.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.801 0.84 . . . . 0.0 110.73 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -129.93 128.14 41.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.16 0.984 . . . . 0.0 108.373 166.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.413 ' HD2' ' HE3' ' A' ' 65' ' ' MET . 44.3 t80 -131.84 145.34 51.5 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.747 1.219 . . . . 0.0 107.924 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.7 m -115.73 122.23 44.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 161' ' ' ASN . 2.4 mm? -54.05 126.91 24.43 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.315 0.507 . . . . 0.0 111.29 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.84 56.79 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.998 0.811 . . . . 0.0 113.793 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -92.0 167.52 12.04 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.399 0.599 . . . . 0.0 110.093 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -35.86 50.48 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.802 0.841 . . . . 0.0 111.425 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -69.28 125.87 28.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.906 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.68 139.92 37.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.689 0.796 . . . . 0.0 110.7 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 157' ' ' ILE . 1.7 tt -86.45 121.88 29.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.711 0.804 . . . . 0.0 109.241 -170.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.4 mt -111.36 121.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.299 0.64 . . . . 0.0 109.651 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.49 106.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 109.277 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -89.81 125.0 35.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 109.237 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -113.76 134.48 54.74 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.327 0.584 . . . . 0.0 109.942 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 60' ' ' SER . 12.8 t70 -122.78 85.3 2.4 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.43 1.092 . . . . 0.0 108.279 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.41 136.6 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.87 -3.64 8.65 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.252 1.021 . . . . 0.0 111.173 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.39 152.63 24.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.304 1.042 . . . . 0.0 109.226 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.44 140.15 18.27 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.087 0.955 . . . . 0.0 113.433 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.13 154.4 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.3 1.04 . . . . 0.0 108.966 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.35 161.85 44.62 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.06 -13.53 38.41 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.365 2.043 . . . . 0.0 112.125 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.41 ' HB2' ' HA2' ' A' ' 145' ' ' GLY . 27.7 m -94.98 2.83 55.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.191 0.996 . . . . 0.0 111.681 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.706 ' HB3' ' HE1' ' A' ' 142' ' ' TYR . 0.7 OUTLIER -65.81 139.18 58.3 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.004 0.522 . . . . 0.0 110.091 170.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -152.8 161.32 42.71 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.444 0.465 . . . . 0.0 110.918 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 113' ' ' VAL . 98.2 mt -100.03 120.7 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -100.13 129.62 9.96 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 2.4 tt -84.82 109.28 17.97 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -119.05 133.95 55.49 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -79.77 143.53 34.38 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 118.438 0.563 . . . . 0.0 110.788 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.91 89.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -138.51 138.57 38.17 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.794 0.838 . . . . 0.0 109.329 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.95 90.77 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -155.83 -176.47 5.97 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m -36.33 111.01 0.47 Allowed Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 125.413 1.485 . . . . 0.0 111.795 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 -19.99 18.78 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.97 3.113 . . . . 0.0 115.754 -168.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.66 -38.03 80.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.519 0.328 . . . . 0.0 110.873 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 m120 40.97 58.34 2.53 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.87 1.668 . . . . 0.0 112.35 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.33 99.76 0.05 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.182 0.593 . . . . 0.0 110.475 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -127.74 -155.78 0.71 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.218 1.407 . . . . 0.0 108.444 -169.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.5 -178.03 6.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.656 0.783 . . . . 0.0 111.582 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.49 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 59.8 p -143.17 170.66 15.31 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.221 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 6.9 mmpt? -89.55 154.31 20.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.137 0.975 . . . . 0.0 110.312 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -87.71 -165.31 1.27 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.315 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -42.94 141.81 1.04 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.277 1.431 . . . . 0.0 113.813 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.24 -22.7 17.51 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.037 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 92' ' ' ILE . 5.4 t -103.88 28.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.4 p -78.04 46.68 0.6 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.703 1.201 . . . . 0.0 112.456 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.16 3.97 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.7 p -107.87 160.69 15.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.812 0.845 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -93.75 -66.84 0.89 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.529 0.732 . . . . 0.0 110.18 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -117.47 129.31 55.74 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.88 -174.96 47.01 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.29 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 151.6 33.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.745 0.818 . . . . 0.0 110.425 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.6 mt -129.17 122.97 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.575 0.75 . . . . 0.0 109.078 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.76 149.82 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 109.686 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -162.62 111.11 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.846 0.858 . . . . 0.0 108.744 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -85.32 107.92 17.56 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.32 116.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.071 0.548 . . . . 0.0 110.231 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.24 152.81 50.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.25 85.8 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.483 2.122 . . . . 0.0 111.577 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.65 -167.55 34.86 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.721 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.02 -18.4 46.11 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.711 2.274 . . . . 0.0 111.945 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -83.4 -37.31 23.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.081 0.952 . . . . 0.0 110.418 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 136' ' ' ILE . 70.9 m-85 -103.36 81.08 1.89 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.669 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 86.5 mtp -128.68 -12.8 4.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.337 1.055 . . . . 0.0 110.501 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 136' ' ' ILE . 35.4 mt-10 -73.08 163.33 69.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.588 0.755 . . . . 0.0 110.176 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.82 -23.75 74.38 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.355 2.036 . . . . 0.0 112.347 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -163.32 110.83 1.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.757 0.823 . . . . 0.0 109.603 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 131' ' ' PHE . 2.9 mp -103.93 116.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.651 1.181 . . . . 0.0 108.68 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.28 130.3 38.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 96' ' ' HIS . 41.9 pt -129.89 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.751 0.82 . . . . 0.0 110.301 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 29.6 p -159.35 130.78 6.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.878 0.871 . . . . 0.0 109.146 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 92' ' ' ILE . 85.1 m-85 -89.89 136.95 32.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.414 1.086 . . . . 0.0 109.308 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.7 mttt -136.38 108.48 7.21 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.236 0.614 . . . . 0.0 110.767 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.706 ' HE1' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -75.65 111.52 11.06 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.37 163.32 12.52 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.198 0.999 . . . . 0.0 110.432 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 66.1 t60 -111.66 102.07 10.4 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.697 0.799 . . . . 0.0 110.732 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 89' ' ' SER . . . 71.33 -74.57 0.69 Allowed Glycine 0 C--N 1.346 1.111 0 O-C-N 123.982 0.801 . . . . 0.0 112.635 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.6 mt -109.82 162.6 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 125.287 1.435 . . . . 0.0 108.36 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 p -77.04 80.49 3.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.159 0.584 . . . . 0.0 110.496 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.44 -65.9 0.01 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 144' ' ' HIS . . . -73.96 109.52 7.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.307 0.643 . . . . 0.0 109.471 173.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 tp -88.82 115.69 26.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.477 0.711 . . . . 0.0 109.36 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 142' ' ' TYR . 29.7 mmm180 -70.07 -54.37 13.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.177 0.591 . . . . 0.0 109.638 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.88 165.84 31.42 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.165 -170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 141' ' ' LYS . 91.5 m -152.02 131.57 13.05 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.786 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.3 p -78.31 145.07 67.68 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.47 164.57 2.87 Favored 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 122.607 2.205 . . . . 0.0 113.179 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 10.8 p -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.653 1.181 . . . . 0.0 111.353 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 76' ' ' LEU . 64.4 mt -84.96 107.46 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.475 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.0 m -75.81 100.21 4.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.634 1.174 . . . . 0.0 110.215 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.41 96.02 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.767 0.827 . . . . 0.0 109.002 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -88.79 146.9 24.72 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.182 1.393 . . . . 0.0 110.4 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.594 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.9 t-20 -126.07 100.64 29.91 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.418 0.687 . . . . 0.0 110.037 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 C--N 1.377 2.027 0 C-N-CA 123.363 2.709 . . . . 0.0 111.575 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 22.9 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -126.83 137.66 53.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.362 0.665 . . . . 0.0 110.203 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' HG13 ' A' ' 82' ' ' ILE . 30.0 m -68.86 111.15 4.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.42 0.688 . . . . 0.0 109.693 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 m -101.86 150.97 22.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.114 0.966 . . . . 0.0 110.81 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.36 119.95 15.06 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.4 p -133.3 178.48 6.87 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 109.516 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -142.67 164.24 30.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.107 0.563 . . . . 0.0 110.687 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -67.38 -40.54 85.69 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.792 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -148.41 135.31 20.03 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.616 1.166 . . . . 0.0 108.789 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -89.84 11.42 20.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.296 0.638 . . . . 0.0 110.789 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -133.48 128.91 36.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 108.845 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 76' ' ' LEU . 28.3 t80 -133.82 144.51 49.02 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 38.4 m -125.04 135.06 52.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.056 0.542 . . . . 0.0 109.968 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.19 139.64 46.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.795 0.438 . . . . 0.0 110.676 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.84 -8.18 65.49 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.167 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 69' ' ' THR . 21.5 pt20 -84.79 157.25 21.05 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 117.293 0.546 . . . . 0.0 109.819 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.68 -19.71 44.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.646 0.778 . . . . 0.0 111.171 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -72.43 145.01 47.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.254 0.621 . . . . 0.0 111.152 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 16.9 m120 -112.84 163.16 14.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.406 1.083 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 68' ' ' TYR . 3.2 tt -119.94 117.82 29.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -100.35 133.77 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.367 0.667 . . . . 0.0 109.922 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.46 115.54 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.177 0.991 . . . . 0.0 109.04 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -103.56 131.67 50.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.285 1.034 . . . . 0.0 109.536 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.48 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.2 p90 -126.83 147.4 50.03 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.926 0.49 . . . . 0.0 109.884 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -135.21 85.67 2.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.117 0.967 . . . . 0.0 108.659 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.9 mp -96.18 102.68 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -72.3 -17.46 61.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.399 1.08 . . . . 0.0 112.093 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.43 163.7 12.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.464 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.69 143.57 24.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.823 1.249 . . . . 0.0 112.948 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.4 155.68 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.57 160.83 28.0 Favored Pre-proline 0 N--CA 1.486 1.328 0 C-N-CA 124.54 1.136 . . . . 0.0 109.208 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.41 -9.92 19.62 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.661 2.241 . . . . 0.0 113.169 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -87.4 -0.96 57.56 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.047 0.939 . . . . 0.0 111.878 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.76 159.31 31.21 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.492 0.717 . . . . 0.0 110.328 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -159.2 157.85 31.56 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.472 0.482 . . . . 0.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.79 125.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 163.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -103.71 141.16 15.17 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.13 115.26 27.53 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -121.18 160.82 23.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.262 1.025 . . . . 0.0 109.836 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 106' ' ' TRP . 11.8 t-160 -95.67 127.3 41.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.058 0.943 . . . . 0.0 110.01 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.37 88.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 166.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.31 150.85 41.34 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.826 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 95.11 2.73 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.31 -171.45 3.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.236 -164.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.1 t -43.33 126.62 3.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.543 1.137 . . . . 0.0 111.357 166.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.82 -27.83 85.82 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.865 2.377 . . . . 0.0 111.511 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.74 57.63 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.849 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 42.03 64.32 1.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.101 1.361 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -52.91 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.905 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -135.8 -156.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.644 1.178 . . . . 0.0 109.484 -168.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -85.48 164.81 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.278 0.631 . . . . 0.0 110.718 -168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 20.3 p -136.04 144.42 45.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.723 1.209 . . . . 0.0 108.781 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.1 mmpt? -85.2 168.02 15.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.472 0.709 . . . . 0.0 112.345 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -83.49 179.9 7.53 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.759 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -53.87 142.67 23.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.619 1.168 . . . . 0.0 111.72 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.8 -21.15 12.7 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -168.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -103.07 7.12 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.88 0.872 . . . . 0.0 110.261 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.8 p -84.01 49.65 1.68 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.764 1.626 . . . . 0.0 111.946 -171.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.83 55.9 3.7 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.375 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -102.66 138.82 39.05 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.11 -68.98 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.997 0.519 . . . . 0.0 110.295 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -130.72 140.7 50.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.88 -166.72 36.03 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 123.66 0.6 . . . . 0.0 112.818 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -157.31 148.83 22.08 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.131 0.572 . . . . 0.0 110.224 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' HH2' ' A' ' 80' ' ' TRP . 66.3 mt -132.22 120.66 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.804 0.842 . . . . 0.0 108.899 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.0 137.52 23.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 37.0 t90 -151.77 123.8 8.12 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 38.3 ptt180 -86.18 143.7 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.487 HG12 ' CZ3' ' A' ' 123' ' ' TRP . 12.5 mt -97.03 140.09 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -117.84 148.05 42.44 Favored Pre-proline 0 N--CA 1.477 0.918 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 85.6 0.75 Allowed 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.591 2.194 . . . . 0.0 110.467 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -102.4 -163.54 26.37 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.976 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -17.87 49.01 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.885 2.39 . . . . 0.0 112.202 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -86.53 -28.49 23.34 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.913 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.584 ' HA ' HG12 ' A' ' 136' ' ' ILE . 64.0 m-85 -115.34 82.8 1.81 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.522 0.729 . . . . 0.0 109.724 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.9 mtm -128.37 -3.39 5.53 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.231 1.012 . . . . 0.0 111.597 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.586 ' HB2' HG13 ' A' ' 136' ' ' ILE . 33.6 mt-10 -82.21 161.02 61.36 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.119 0.568 . . . . 0.0 109.849 175.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.7 -24.73 68.96 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.207 1.938 . . . . 0.0 111.472 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -155.0 105.64 2.57 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.717 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.586 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -99.25 111.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.897 1.279 . . . . 0.0 108.932 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -87.35 122.24 30.84 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.64 171.49 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.746 . . . . 0.0 110.191 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 16.5 p -153.58 128.25 9.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.617 0.767 . . . . 0.0 109.434 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.417 ' HE1' ' HD2' ' A' ' 109' ' ' LYS . 86.5 m-85 -88.46 130.68 35.14 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.04 0.936 . . . . 0.0 109.154 175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 94.5 mttt -128.65 103.58 7.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.407 0.683 . . . . 0.0 109.66 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.59 100.23 2.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -91.05 150.17 21.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.244 0.618 . . . . 0.0 109.675 170.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -81.73 169.42 16.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.744 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.28 -30.88 49.32 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 123.428 0.537 . . . . 0.0 113.961 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.89 109.6 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 p -63.83 96.42 0.13 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.697 0.799 . . . . 0.0 110.653 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 143.6 -39.23 1.3 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.08 120.77 14.24 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.881 0.872 . . . . 0.0 109.846 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.1 tp -99.79 120.34 39.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.398 0.679 . . . . 0.0 110.346 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 15.1 mmt180 -79.04 -53.6 6.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.903 0.481 . . . . 0.0 110.574 171.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.19 161.17 37.81 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.2 m -148.16 134.65 19.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.862 0.865 . . . . 0.0 110.521 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 46.3 p -76.03 148.93 82.08 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.401 0.68 . . . . 0.0 109.356 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 173.53 2.76 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.075 1.85 . . . . 0.0 112.271 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.3 p -63.61 102.75 0.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.279 1.032 . . . . 0.0 111.143 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -83.65 112.37 21.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.107 0.963 . . . . 0.0 109.313 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.9 m -81.73 101.31 10.02 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.818 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.1 t -98.09 98.09 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.517 1.127 . . . . 0.0 109.257 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -89.52 135.2 33.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.651 0.78 . . . . 0.0 108.965 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -125.56 98.27 34.96 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.374 0.67 . . . . 0.0 109.919 -167.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 124.131 3.22 . . . . 0.0 110.86 177.403 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -125.52 -177.71 3.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.22 1.008 . . . . 0.0 110.806 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 m -44.38 128.97 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.319 1.447 . . . . 0.0 111.985 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.0 m -121.96 139.27 53.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.707 0.803 . . . . 0.0 110.4 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 61' ' ' LEU . 8.3 mt -115.48 133.81 55.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.796 0.838 . . . . 0.0 109.546 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -140.08 168.9 18.74 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.98 1.312 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.28 153.69 43.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.028 0.531 . . . . 0.0 110.487 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -60.26 -29.36 68.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.882 0.873 . . . . 0.0 110.535 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -162.04 138.88 8.18 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.468 1.107 . . . . 0.0 108.884 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -100.86 21.28 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.268 0.627 . . . . 0.0 110.067 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 158' ' ' THR . 46.2 mt-10 -139.7 153.05 47.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.45 1.1 . . . . 0.0 109.077 170.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 13.4 t80 -159.64 146.99 16.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -174.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.6 m -130.5 128.1 40.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -61.46 109.65 1.23 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.27 0.628 . . . . 0.0 110.716 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.81 -0.09 10.93 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.902 0.751 . . . . 0.0 112.98 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -83.98 154.87 23.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 117.282 0.541 . . . . 0.0 109.989 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.01 53.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.322 0.649 . . . . 0.0 111.777 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -74.6 119.89 19.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.16 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 9.8 m120 -94.4 157.11 16.17 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.099 0.56 . . . . 0.0 109.823 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 157' ' ' ILE . 0.5 OUTLIER -83.21 112.93 20.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.017 0.527 . . . . 0.0 109.817 -168.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 120' ' ' GLN . 4.6 mt -93.54 114.84 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 49.7 mm -94.75 111.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.076 0.551 . . . . 0.0 109.692 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.55 121.91 37.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.013 0.925 . . . . 0.0 109.152 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -104.55 130.0 52.55 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.33 93.25 4.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.336 1.454 . . . . 0.0 107.388 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 84' ' ' GLU . 29.1 mt -118.55 105.0 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.42 55.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.244 0.618 . . . . 0.0 109.995 171.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . 11.0 tp10 -76.78 157.72 31.39 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 110.542 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.67 133.07 53.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.731 0.813 . . . . 0.0 112.422 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.63 ' HA ' HH12 ' A' ' 151' ' ' ARG . 19.2 m -113.91 171.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.573 0.749 . . . . 0.0 110.959 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -167.06 135.82 2.2 Favored Pre-proline 0 C--O 1.21 -0.981 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.38 -9.4 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.701 2.934 . . . . 0.0 116.296 -174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -74.0 -5.38 41.0 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 0.0 112.116 172.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.14 151.36 23.41 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 123.368 0.667 . . . . 0.0 110.753 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HH2' ' H ' ' A' ' 147' ' ' SER . 2.6 p90 -163.12 170.66 17.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 109.675 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.488 HG13 HG11 ' A' ' 113' ' ' VAL . 81.8 mt -100.64 123.08 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 172.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.56 141.9 15.57 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' TRP . 6.0 tt -98.62 113.89 26.13 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -116.16 161.11 19.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.157 0.983 . . . . 0.0 109.384 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.22 150.58 20.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.276 0.63 . . . . 0.0 109.613 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 139' ' ' CYS . 36.7 mm -86.56 87.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -141.8 128.32 20.15 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.798 0.839 . . . . 0.0 109.742 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.56 91.5 1.84 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.462 1.125 . . . . 0.0 109.118 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -159.86 -166.62 1.78 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.946 -163.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 m -35.57 115.16 0.56 Allowed Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 125.006 1.323 . . . . 0.0 112.736 170.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.25 -32.35 62.34 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.458 2.772 . . . . 0.0 114.076 -168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.32 76.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.67 0.388 . . . . 0.0 110.691 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.2 57.24 3.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.968 1.707 . . . . 0.0 112.189 170.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -55.06 111.07 0.76 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.267 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -142.42 -152.6 0.42 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.841 1.657 . . . . 0.0 107.805 -169.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -83.71 168.5 16.19 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 -169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.3 m -143.6 153.24 42.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.536 0.734 . . . . 0.0 109.553 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.08 159.57 20.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.86 0.838 . . . . 0.0 112.825 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -97.3 -163.81 1.08 Allowed 'General case' 0 C--O 1.244 0.802 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.969 -169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.74 141.5 5.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.018 1.327 . . . . 0.0 112.999 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.23 8.73 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.137 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG11 HG13 ' A' ' 92' ' ' ILE . 2.3 t -105.0 28.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.827 0.851 . . . . 0.0 110.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 t -76.73 45.1 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.601 1.16 . . . . 0.0 112.695 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.62 57.32 4.61 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -104.91 131.32 52.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.546 0.738 . . . . 0.0 109.504 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.43 HE21 HG22 ' A' ' 86' ' ' VAL . 15.5 mm-40 -59.48 -56.52 20.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.399 1.08 . . . . 0.0 110.851 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -142.01 138.81 32.11 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.95 -171.64 43.05 Favored Glycine 0 C--O 1.238 0.38 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.466 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -149.09 151.5 34.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.208 0.603 . . . . 0.0 111.159 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 mt -133.3 110.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.299 0.64 . . . . 0.0 109.365 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.6 p -79.76 90.26 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.46 1.124 . . . . 0.0 109.783 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.455 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.8 t90 -91.41 123.57 34.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.455 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -78.82 114.87 18.12 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.33 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 HD11 HD12 ' A' ' 76' ' ' LEU . 6.6 mt -81.59 123.67 38.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.82 140.83 39.23 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 73.8 Cg_endo -70.57 85.29 0.74 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.881 2.387 . . . . 0.0 112.75 -173.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.8 -156.77 32.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.157 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 -19.72 34.74 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.641 2.227 . . . . 0.0 113.015 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -84.95 -31.98 23.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.257 0.623 . . . . 0.0 110.83 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 26.1 m-85 -100.95 82.65 2.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.346 0.594 . . . . 0.0 109.913 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.6 mtp -122.95 -16.07 7.17 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 136' ' ' ILE . 31.0 mt-10 -69.89 154.7 94.47 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.619 0.768 . . . . 0.0 110.297 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.27 -20.89 67.23 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.349 2.033 . . . . 0.0 111.662 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.56 112.31 2.69 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.176 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.5 mp -94.84 113.85 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.128 0.971 . . . . 0.0 108.949 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.22 108.93 17.98 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -111.34 172.2 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 141' ' ' LYS . 23.1 p -160.82 139.64 10.21 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.99 0.916 . . . . 0.0 108.549 174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -96.92 134.28 40.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 139' ' ' CYS . 96.8 mttt -133.79 104.96 6.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 103.48 6.21 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -94.9 163.06 13.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.723 0.809 . . . . 0.0 109.918 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -129.78 118.12 21.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.17 153.25 28.31 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.1 pt -60.23 87.08 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 C-N-CA 123.875 0.87 . . . . 0.0 112.221 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.578 ' H ' ' HH2' ' A' ' 91' ' ' TRP . 22.7 t 62.6 29.25 16.92 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 125.206 1.403 . . . . 0.0 111.014 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.32 -107.4 0.78 Allowed Glycine 0 C--N 1.355 1.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.074 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 161.21 21.29 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.617 0.767 . . . . 0.0 111.353 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 tp -103.77 138.53 40.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.664 0.786 . . . . 0.0 109.381 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.63 HH12 ' HA ' ' A' ' 86' ' ' VAL . 11.4 mtp180 -101.91 -55.39 2.51 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.841 0.856 . . . . 0.0 109.986 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.78 43.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.235 -169.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 141' ' ' LYS . 76.6 m -151.97 133.71 14.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.904 0.882 . . . . 0.0 109.82 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.6 p -79.19 148.03 70.36 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.25 164.49 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.468 2.779 . . . . 0.0 113.929 167.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.86 104.29 1.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.879 0.871 . . . . 0.0 111.037 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 76' ' ' LEU . 79.4 mt -83.11 116.39 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.705 0.802 . . . . 0.0 110.17 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 89.4 m -78.96 101.67 7.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.177 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 125' ' ' ILE . 44.8 t -107.4 100.64 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.36 133.8 33.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.609 0.764 . . . . 0.0 109.338 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -113.4 100.58 52.08 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.303 2.669 . . . . 0.0 111.983 -177.254 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 179.9 3.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.372 0.669 . . . . 0.0 111.637 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 12.9 m -51.12 118.34 3.15 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.405 1.482 . . . . 0.0 111.145 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.6 m -122.12 125.98 47.35 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 -176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.89 139.37 33.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 0.0 110.471 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 p -143.79 172.36 12.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.446 1.499 . . . . 0.0 108.883 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.28 155.48 47.71 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.591 0.756 . . . . 0.0 109.285 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB3' ' HE1' ' A' ' 79' ' ' PHE . 61.1 p -61.82 -36.24 80.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.339 0.656 . . . . 0.0 110.844 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -154.52 139.99 17.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.474 1.11 . . . . 0.0 109.15 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -103.09 19.62 19.18 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.69 0.796 . . . . 0.0 110.34 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.68 121.47 17.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.366 1.066 . . . . 0.0 108.486 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 76' ' ' LEU . 22.5 t80 -144.94 117.7 8.7 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.174 0.59 . . . . 0.0 109.967 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.8 m -83.28 131.06 35.11 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.34 125.41 14.2 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.544 0.738 . . . . 0.0 111.991 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.29 27.69 73.55 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.768 0.668 . . . . 0.0 114.459 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.65 177.9 5.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.254 0.527 . . . . 0.0 111.564 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.94 -52.23 51.6 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.607 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -86.91 150.87 23.78 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -102.91 142.97 33.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.208 1.003 . . . . 0.0 110.152 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 68' ' ' TYR . 4.0 tt -93.21 123.01 36.18 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 HG23 ' A' ' 122' ' ' VAL . 18.2 mt -111.25 135.75 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 122.989 0.516 . . . . 0.0 109.952 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.54 112.48 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.06 0.944 . . . . 0.0 109.003 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 64' ' ' SER . 78.2 m-85 -99.12 122.64 42.61 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.047 0.939 . . . . 0.0 109.647 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.51 ' HH2' HG13 ' A' ' 121' ' ' ILE . 49.4 p90 -111.09 145.3 38.8 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 170.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.71 92.81 2.94 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 10.7 mm -96.78 107.35 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.622 -172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.55 -41.24 55.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.514 0.725 . . . . 0.0 110.366 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.37 174.93 11.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.672 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -63.16 151.93 38.82 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.987 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.9 m -119.42 155.83 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.26 1.024 . . . . 0.0 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 55.2 m-20 -114.89 143.04 29.34 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.534 0.734 . . . . 0.0 109.399 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.09 -23.22 51.59 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.81 2.34 . . . . 0.0 113.533 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.2 m -95.38 22.44 6.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.416 0.686 . . . . 0.0 111.734 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 2.2 t70 -77.2 149.48 35.52 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.446 ' HH2' ' HA2' ' A' ' 148' ' ' GLY . 6.9 p90 -152.12 151.32 30.91 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.724 0.773 . . . . 0.0 111.998 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -111.18 131.38 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.194 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -102.06 139.0 14.22 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.62 -0.544 . . . . 0.0 111.883 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.3 108.36 20.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.09 145.69 43.61 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.077 0.951 . . . . 0.0 109.619 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.428 ' ND1' ' HB2' ' A' ' 98' ' ' ASP . 16.4 t-80 -92.23 132.0 37.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.804 0.842 . . . . 0.0 109.103 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -63.18 100.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' ND1' ' A' ' 96' ' ' HIS . 25.9 t0 -133.96 138.08 45.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.966 0.906 . . . . 0.0 109.637 -173.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.55 88.68 7.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.41 -169.02 2.16 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.027 0.931 . . . . 0.0 108.877 -170.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -39.56 124.19 1.45 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.048 1.339 . . . . 0.0 112.354 164.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.09 -11.74 32.46 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.626 2.217 . . . . 0.0 113.382 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -38.67 81.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.199 0.6 . . . . 0.0 111.118 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 m120 38.54 61.07 1.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.852 1.261 . . . . 0.0 112.59 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -51.61 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.548 0.739 . . . . 0.0 111.522 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.81 -162.66 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.009 -171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -86.14 -179.31 6.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 111.524 -165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 51.8 m -143.34 163.73 32.22 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.54 1.136 . . . . 0.0 109.485 172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 8.4 mmpt? -86.7 160.78 18.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.639 0.776 . . . . 0.0 110.325 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -85.08 -167.17 1.73 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.106 0.962 . . . . 0.0 110.597 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -59.18 154.79 15.37 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.699 0.8 . . . . 0.0 112.401 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.88 -23.02 10.3 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.039 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG13 HD12 ' A' ' 121' ' ' ILE . 32.5 m -102.22 17.53 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.413 1.085 . . . . 0.0 109.618 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.4 p -81.91 48.91 1.28 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.745 1.618 . . . . 0.0 112.486 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.85 56.26 3.88 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.065 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -105.2 126.84 52.53 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.247 1.019 . . . . 0.0 109.061 171.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -60.67 -30.45 69.93 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.504 1.122 . . . . 0.0 113.181 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -167.38 123.65 1.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.4 -175.32 38.52 Favored Glycine 0 CA--C 1.507 -0.457 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.87 150.95 37.09 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.077 0.465 . . . . 0.0 111.758 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.51 HG13 ' HH2' ' A' ' 80' ' ' TRP . 24.3 mt -127.01 118.37 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.017 0.927 . . . . 0.0 108.788 173.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.401 HG23 HG12 ' A' ' 77' ' ' ILE . 11.1 p -82.06 143.51 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.491 0.716 . . . . 0.0 109.663 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -152.26 122.17 7.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.009 0.924 . . . . 0.0 108.856 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -94.33 111.85 23.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.8 117.2 23.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 122.977 0.511 . . . . 0.0 110.475 -166.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.06 143.13 29.39 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.97 0.908 . . . . 0.0 108.961 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.63 80.42 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.258 1.972 . . . . 0.0 111.803 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.44 -175.29 48.89 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.787 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -20.77 64.3 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.968 2.445 . . . . 0.0 113.019 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -71.62 -37.24 70.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.658 0.783 . . . . 0.0 111.155 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 136' ' ' ILE . 41.3 m-85 -89.85 83.07 6.16 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.461 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 70.5 mtm -120.04 -0.14 10.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.697 0.799 . . . . 0.0 112.081 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.0 mt-10 -83.34 159.93 60.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.29 -34.76 98.93 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.065 1.843 . . . . 0.0 111.214 166.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -147.0 113.82 6.09 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.036 0.934 . . . . 0.0 108.942 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.4 mp -92.13 119.47 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.047 0.939 . . . . 0.0 110.561 -176.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.19 108.9 20.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.8 pt -109.86 171.76 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.671 0.389 . . . . 0.0 110.257 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 28.3 p -162.66 125.92 2.89 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.123 0.969 . . . . 0.0 108.913 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -85.04 142.49 29.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.87 0.868 . . . . 0.0 109.407 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -133.75 101.13 4.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.352 0.661 . . . . 0.0 110.704 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 57.2 t80 -70.79 103.98 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.168 0.987 . . . . 0.0 109.42 176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.37 135.41 40.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -76.16 140.57 41.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.082 0.239 . . . . 0.0 110.358 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.31 -72.83 0.45 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 124.6 1.187 . . . . 0.0 115.044 -170.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mt -90.82 66.86 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.2 m -160.9 -57.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.368 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.446 ' HA2' ' HH2' ' A' ' 91' ' ' TRP . . . 90.02 -21.48 30.6 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.202 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.23 158.91 24.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.634 0.774 . . . . 0.0 111.64 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.5 tp -79.56 127.58 32.32 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.352 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB2' ' HD1' ' A' ' 142' ' ' TYR . 7.8 mmt180 -104.84 -45.21 4.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.424 0.69 . . . . 0.0 111.105 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 142' ' ' TYR . . . -143.35 154.69 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.8 m -146.8 134.61 21.23 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.184 0.994 . . . . 0.0 109.46 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -70.36 136.82 86.37 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.55 146.26 7.92 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.089 2.526 . . . . 0.0 112.89 167.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.7 m -52.24 108.27 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.876 1.27 . . . . 0.0 112.321 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.1 mt -85.37 110.25 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.873 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 28.4 m -78.62 99.26 6.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -92.21 106.93 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -88.79 130.72 35.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.836 0.855 . . . . 0.0 110.378 -167.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -119.2 106.25 43.31 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.762 -171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.37 1.693 0 C-N-CA 123.233 2.622 . . . . 0.0 110.623 173.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 22.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.74 170.11 9.68 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -59.95 121.21 11.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.224 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.8 m -111.17 132.12 54.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.204 0.602 . . . . 0.0 111.099 -173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 2.1 mt -110.88 131.9 54.66 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p -143.67 171.5 14.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 109.248 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.58 163.8 30.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 110.336 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.6 p -64.93 -28.23 69.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.444 0.697 . . . . 0.0 111.005 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -161.55 154.23 20.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.886 1.274 . . . . 0.0 108.414 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -113.41 27.58 9.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.495 0.664 . . . . 0.0 109.997 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -142.9 133.2 24.66 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.972 1.309 . . . . 0.0 108.756 171.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.408 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 t80 -141.87 117.33 10.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -96.3 126.45 41.52 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.161 0.584 . . . . 0.0 109.488 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 125' ' ' ILE . 3.7 mm? -62.14 122.59 15.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.758 0.423 . . . . 0.0 110.337 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.76 26.84 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.79 0.681 . . . . 0.0 113.334 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.86 163.61 21.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.241 0.543 . . . . 0.0 110.985 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HA ' HH22 ' A' ' 124' ' ' ARG . . . -84.07 -33.09 24.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.038 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.6 131.59 45.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.42 0.688 . . . . 0.0 110.923 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.408 ' HA ' ' HE2' ' A' ' 68' ' ' TYR . 71.0 m-20 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.266 0.626 . . . . 0.0 110.084 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.4 tp -90.18 102.68 15.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 110.251 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 12.6 mt -93.44 116.48 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.61 106.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.152 0.981 . . . . 0.0 109.334 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -93.39 132.74 37.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.316 1.046 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -130.41 144.15 51.21 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -136.08 98.9 3.99 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.53 117.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.42 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 57' ' ' SER . 76.0 mmtt -80.52 -42.43 22.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.454 0.701 . . . . 0.0 110.444 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.87 149.55 46.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.474 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 139.28 46.47 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.931 0.769 . . . . 0.0 111.041 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 115' ' ' GLY . 9.6 m -105.97 171.11 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.913 0.885 . . . . 0.0 111.447 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -158.67 136.18 7.12 Favored Pre-proline 0 C--O 1.214 -0.809 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.86 8.33 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.807 2.338 . . . . 0.0 115.766 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 t -86.34 -13.04 47.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.383 0.673 . . . . 0.0 111.085 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 10.5 p30 -86.28 166.15 15.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.924 0.49 . . . . 0.0 111.787 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.41 ' HA ' HG23 ' A' ' 113' ' ' VAL . 18.5 p90 -161.93 170.21 19.8 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.634 -171.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 109' ' ' LYS . 56.6 mt -109.48 120.69 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.64 134.07 11.66 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 138' ' ' ILE . 3.5 tt -102.81 104.98 15.3 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.94 151.59 21.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.133 0.973 . . . . 0.0 110.27 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 106' ' ' TRP . 10.9 t-160 -90.05 125.9 35.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.544 1.138 . . . . 0.0 109.141 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.67 86.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.66 155.36 44.91 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.016 . . . . 0.0 109.121 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.01 90.7 4.19 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -143.65 -173.09 3.87 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.681 -166.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 m -43.33 126.71 3.63 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.944 1.298 . . . . 0.0 112.344 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.0 -34.71 58.05 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.186 2.591 . . . . 0.0 113.21 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.57 72.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.756 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 41.58 69.38 0.36 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.772 1.629 . . . . 0.0 111.997 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -53.14 102.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.273 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -150.06 -153.93 0.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.441 -169.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . 23.4 t70 -85.42 170.52 12.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -166.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -148.25 151.86 36.17 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.948 0.899 . . . . 0.0 109.672 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.533 ' HE2' ' HE2' ' A' ' 140' ' ' PHE . 3.3 mmpm? -86.11 137.9 32.33 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.121 0.569 . . . . 0.0 110.454 171.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.11 -166.92 1.64 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.821 1.248 . . . . 0.0 111.026 -172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 114' ' ' THR . 70.0 mtp85 -49.48 146.7 3.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.582 0.753 . . . . 0.0 112.98 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.46 -23.67 12.05 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.623 -168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 91' ' ' TRP . 18.1 m -103.31 14.43 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.18 0.992 . . . . 0.0 109.509 171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 111' ' ' ARG . 14.6 p -82.07 55.01 2.66 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 126.611 1.964 . . . . 0.0 112.014 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . 81.26 60.22 2.28 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.389 -0.368 . . . . 0.0 113.04 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 p -117.5 121.65 41.59 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.019 0.928 . . . . 0.0 110.603 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -60.73 -28.1 68.42 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.806 1.242 . . . . 0.0 111.947 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -151.42 138.41 19.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.62 48.64 Favored Glycine 0 C--N 1.336 0.56 0 O-C-N 123.258 0.349 . . . . 0.0 112.821 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 149.87 30.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.684 0.793 . . . . 0.0 110.431 173.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.98 110.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.092 0.957 . . . . 0.0 108.43 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 7.2 p -72.91 125.84 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 31.5 t90 -137.45 113.54 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.352 0.661 . . . . 0.0 109.637 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.414 HH22 ' HA ' ' A' ' 73' ' ' ALA . 16.2 ttm-85 -76.3 132.81 40.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.548 0.739 . . . . 0.0 109.516 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 70' ' ' LEU . 46.5 mt -93.6 129.86 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -121.12 146.57 44.6 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.349 1.06 . . . . 0.0 109.481 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' HD12 ' A' ' 70' ' ' LEU . 89.5 Cg_endo -74.83 80.09 2.46 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.781 2.321 . . . . 0.0 112.176 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.29 -157.07 29.81 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.921 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.76 -27.76 81.17 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 123.422 2.748 . . . . 0.0 113.119 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -89.24 -22.89 22.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.858 0.863 . . . . 0.0 111.587 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HA ' HG12 ' A' ' 136' ' ' ILE . 61.2 m-85 -118.47 81.19 1.64 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.945 0.498 . . . . 0.0 109.783 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.2 mtp -128.33 -5.0 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.521 0.728 . . . . 0.0 111.329 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HB2' HG13 ' A' ' 136' ' ' ILE . 46.6 mt-10 -71.64 162.24 74.18 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.286 0.635 . . . . 0.0 110.252 174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.94 -24.85 45.41 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.145 1.897 . . . . 0.0 111.9 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -154.53 108.61 2.96 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.778 0.831 . . . . 0.0 109.296 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 133' ' ' GLU . 3.0 mp -102.99 108.83 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.445 1.098 . . . . 0.0 108.451 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -85.85 118.56 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 94' ' ' LEU . 47.1 pt -119.93 171.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.114 0.566 . . . . 0.0 110.589 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.1 p -156.98 154.52 29.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.722 0.809 . . . . 0.0 109.811 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.533 ' HE2' ' HE2' ' A' ' 109' ' ' LYS . 63.1 m-85 -116.79 138.69 51.31 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.611 1.164 . . . . 0.0 108.006 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.23 105.89 6.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.011 0.524 . . . . 0.0 110.94 -172.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -79.97 102.02 8.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 96.9 m-85 -83.45 166.8 18.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.378 1.071 . . . . 0.0 109.728 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -123.91 87.42 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.177 0.591 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.7 -74.3 0.76 Allowed Glycine 0 C--N 1.343 0.969 0 O-C-N 123.985 0.803 . . . . 0.0 113.518 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.58 133.16 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 124.306 1.042 . . . . 0.0 110.823 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -71.32 84.68 0.79 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.387 0.675 . . . . 0.0 109.878 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.03 -31.12 0.73 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.374 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.67 106.57 9.56 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.0 tp -101.78 132.37 47.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.243 0.617 . . . . 0.0 110.028 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -107.83 -42.29 4.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.731 0.813 . . . . 0.0 111.513 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -146.08 151.58 37.93 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -172.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.8 m -147.4 130.92 16.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.561 1.144 . . . . 0.0 109.141 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 p -71.75 143.34 86.93 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.669 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.74 138.38 50.28 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.345 2.03 . . . . 0.0 110.904 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 7.9 p -55.13 120.18 6.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.901 0.88 . . . . 0.0 112.527 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.77 115.17 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 3.1 m -80.09 102.55 9.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.807 0.843 . . . . 0.0 109.157 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.7 110.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.525 0.73 . . . . 0.0 109.685 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 160' ' ' LYS . 0.1 OUTLIER -92.5 130.51 38.14 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.484 0.714 . . . . 0.0 109.309 -178.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 51.9 t30 -120.32 93.32 48.1 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.923 0.889 . . . . 0.0 108.985 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 123.199 2.599 . . . . 0.0 111.005 177.511 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.239 0.541 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -83.14 177.59 8.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.766 0.826 . . . . 0.0 109.901 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 82' ' ' ILE . 69.4 m -69.27 112.6 5.95 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.605 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 m -114.87 115.26 26.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.696 0.798 . . . . 0.0 110.65 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 80' ' ' TRP . 20.7 tp -98.18 111.17 23.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 170.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -114.86 165.56 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.134 0.973 . . . . 0.0 110.298 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.09 151.62 51.67 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 p -60.43 -32.41 71.34 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.404 0.682 . . . . 0.0 111.143 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -160.32 130.5 5.34 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.896 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -91.81 20.72 5.37 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.208 0.603 . . . . 0.0 110.746 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -143.61 145.85 32.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.398 1.479 . . . . 0.0 107.834 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -154.03 143.79 21.76 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.1 m -120.05 129.02 54.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.254 0.622 . . . . 0.0 109.5 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.8 126.46 27.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.765 0.426 . . . . 0.0 110.487 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.32 -13.16 25.95 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.659 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -77.74 155.53 31.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.134 0.492 . . . . 0.0 110.701 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 -21.23 32.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.469 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -71.28 124.47 24.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.504 0.322 . . . . 0.0 110.256 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.97 156.98 16.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.931 0.892 . . . . 0.0 110.441 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.7 tp -93.93 108.78 20.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.69 0.796 . . . . 0.0 109.495 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.49 115.23 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 108.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -91.26 163.29 14.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.833 0.853 . . . . 0.0 109.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.507 ' HB3' HD12 ' A' ' 61' ' ' LEU . 45.6 p90 -157.4 150.45 23.5 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 112.105 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.88 86.92 2.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.786 1.634 . . . . 0.0 108.561 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.6 HG13 ' HB3' ' A' ' 59' ' ' SER . 1.6 mp -93.91 108.72 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -20.53 59.88 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.026 0.931 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.23 147.33 40.41 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.823 1.249 . . . . 0.0 110.07 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.57 106.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.648 0.779 . . . . 0.0 111.332 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.27 155.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.279 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -128.88 151.07 76.8 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.004 0.922 . . . . 0.0 109.496 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.49 13.29 2.11 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.5 2.133 . . . . 0.0 112.699 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.1 m -105.86 -0.41 25.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.25 1.02 . . . . 0.0 112.056 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.13 38.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.31 0.576 . . . . 0.0 111.204 176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' HZ3' ' HA ' ' A' ' 146' ' ' ILE . 8.6 p90 -146.64 179.71 7.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.598 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.93 122.13 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.74 133.01 11.46 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 108' ' ' SER . 4.3 tt -97.64 103.0 14.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -111.85 150.71 30.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.736 0.814 . . . . 0.0 110.334 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -93.35 147.94 22.49 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.74 102.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -137.37 129.51 29.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.703 0.801 . . . . 0.0 109.703 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.28 90.31 6.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -156.79 -172.64 4.13 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -163.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 m -44.9 118.98 3.74 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.676 1.191 . . . . 0.0 112.083 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.47 -5.85 15.06 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.26 2.64 . . . . 0.0 114.786 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.26 -39.47 32.99 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.644 0.378 . . . . 0.0 110.537 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 m120 33.91 58.45 0.58 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.749 1.619 . . . . 0.0 114.133 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -54.17 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.457 0.646 . . . . 0.0 112.077 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.13 -154.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.874 1.27 . . . . 0.0 108.514 -174.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.93 -175.2 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' A' ' 94' ' ' LEU . 58.1 p -144.72 175.35 10.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.906 0.483 . . . . 0.0 110.88 175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -87.7 172.41 9.71 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 109.897 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.43 -173.9 4.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.113 0.965 . . . . 0.0 109.98 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -53.47 155.61 2.87 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.112 1.365 . . . . 0.0 111.629 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.62 -16.21 7.02 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 -173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.33 26.39 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.898 0.879 . . . . 0.0 109.533 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.9 p -82.14 51.09 1.7 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.609 1.164 . . . . 0.0 111.808 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.75 57.62 3.03 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.329 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.9 p -112.52 125.56 54.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.183 0.993 . . . . 0.0 110.605 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.37 -68.83 0.34 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.094 0.958 . . . . 0.0 109.876 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -100.67 131.85 46.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.08 -174.87 32.49 Favored Glycine 0 C--O 1.24 0.528 0 C-N-CA 121.539 -0.363 . . . . 0.0 112.756 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.07 145.26 13.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.647 0.779 . . . . 0.0 110.373 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' HH2' ' A' ' 80' ' ' TRP . 75.0 mt -132.8 115.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 0.0 109.193 172.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.82 140.38 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.518 0.727 . . . . 0.0 109.733 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.459 ' CZ3' HG12 ' A' ' 125' ' ' ILE . 33.2 t90 -157.48 125.46 5.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.496 0.718 . . . . 0.0 109.285 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 HG11 ' A' ' 159' ' ' VAL . 13.6 mt -82.04 122.99 37.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -118.59 141.57 30.08 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.57 1.148 . . . . 0.0 108.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 131' ' ' PHE . 72.3 Cg_endo -72.21 82.65 1.3 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.078 2.518 . . . . 0.0 112.032 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.06 -160.8 36.32 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.197 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.62 -21.77 45.16 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.66 2.24 . . . . 0.0 112.127 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.3 -16.75 41.94 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.239 1.016 . . . . 0.0 111.859 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 127' ' ' PRO . 41.2 m-85 -125.56 82.95 2.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.418 0.687 . . . . 0.0 109.509 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 85.8 mtp -124.67 5.25 8.19 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.556 0.742 . . . . 0.0 111.2 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.92 158.91 58.4 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 0.0 110.105 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.91 -27.23 30.93 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.08 1.853 . . . . 0.0 111.288 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -145.62 105.2 3.97 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.903 . . . . 0.0 108.788 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.414 HG21 ' HD1' ' A' ' 131' ' ' PHE . 3.6 mp -87.2 146.53 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.962 0.905 . . . . 0.0 108.587 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -131.34 107.93 9.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.674 1.19 . . . . 0.0 107.868 176.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.09 170.85 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.467 0.707 . . . . 0.0 110.018 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -152.88 158.15 41.74 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.487 1.115 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.01 139.63 52.21 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HG2' HG23 ' A' ' 153' ' ' THR . 94.2 mttt -133.99 103.34 5.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.365 0.666 . . . . 0.0 110.266 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -74.62 114.98 13.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -94.5 170.37 9.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.481 1.113 . . . . 0.0 112.123 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 106.11 8.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.911 1.684 . . . . 0.0 107.068 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.97 165.1 40.46 Favored Glycine 0 C--O 1.244 0.758 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.496 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' ' HZ3' ' A' ' 91' ' ' TRP . 65.6 mt -63.88 97.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.371 0.668 . . . . 0.0 109.658 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.6 p 50.39 44.19 26.76 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.454 1.502 . . . . 0.0 111.439 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.21 -126.41 5.34 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.295 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.75 162.75 28.98 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.095 0.958 . . . . 0.0 111.114 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 tp -105.17 117.28 33.61 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.347 0.659 . . . . 0.0 109.755 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 mtt-85 -78.11 -53.6 7.2 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.842 0.457 . . . . 0.0 110.279 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.12 40.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.171 0.588 . . . . 0.0 111.308 -170.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.1 m -149.81 138.84 21.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.143 0.977 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 57.4 p -81.57 157.58 69.7 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.577 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.07 175.23 9.46 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 121.832 1.688 . . . . 0.0 110.067 165.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 26.6 p -63.71 119.21 9.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.648 0.379 . . . . 0.0 111.524 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.11 113.64 22.61 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.9 m -79.59 98.69 6.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.109 0.881 . . . . 0.0 109.376 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.524 HG11 HG21 ' A' ' 125' ' ' ILE . 19.8 t -101.63 95.69 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.031 0.932 . . . . 0.0 108.88 -178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.26 137.46 32.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.133 0.573 . . . . 0.0 110.573 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.58 105.48 57.18 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.177 0.991 . . . . 0.0 109.305 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 122.92 2.413 . . . . 0.0 111.419 178.409 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 58' ' ' ARG . 3.3 mpt_? -93.09 179.1 5.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.256 0.622 . . . . 0.0 110.727 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.466 ' HB3' HD12 ' A' ' 82' ' ' ILE . 25.9 m -62.16 126.38 27.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.533 176.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.0 p -130.87 150.72 51.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 mt -114.93 145.2 42.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.348 1.059 . . . . 0.0 109.81 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.3 p -144.57 154.08 42.48 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.61 1.164 . . . . 0.0 108.887 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.26 154.9 32.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.07 0.548 . . . . 0.0 109.907 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 p -61.29 -30.77 70.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.129 0.572 . . . . 0.0 110.841 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -159.71 138.98 11.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.123 0.969 . . . . 0.0 109.159 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -97.68 17.1 18.66 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.198 0.599 . . . . 0.0 110.862 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -132.77 145.35 50.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.554 1.142 . . . . 0.0 108.552 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -148.6 122.05 9.1 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.5 m -104.6 116.82 32.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.13 149.97 43.94 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 111.594 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.16 -1.18 86.35 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.559 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -81.65 165.55 20.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.465 0.633 . . . . 0.0 111.041 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.97 -28.89 49.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -73.73 166.69 22.85 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.142 0.577 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -138.3 167.77 21.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.223 1.009 . . . . 0.0 110.898 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD22 HD11 ' A' ' 125' ' ' ILE . 47.4 tp -106.41 130.97 54.13 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.486 0.714 . . . . 0.0 109.479 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.472 HG12 HG23 ' A' ' 122' ' ' VAL . 17.4 mt -120.77 122.77 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.52 107.97 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.544 0.738 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.78 129.24 38.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.119 0.967 . . . . 0.0 109.453 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.494 ' HH2' HG13 ' A' ' 121' ' ' ILE . 43.7 p90 -115.0 135.02 54.68 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 170.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -119.74 97.19 5.51 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 59' ' ' SER . 22.2 mm -111.96 111.2 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.021 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.27 -22.41 48.32 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.25 0.62 . . . . 0.0 110.901 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.18 154.62 37.56 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.847 1.259 . . . . 0.0 110.703 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -60.25 124.27 19.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.33 0.652 . . . . 0.0 109.847 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HH12 ' A' ' 151' ' ' ARG . 13.2 m -96.09 143.99 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.336 1.054 . . . . 0.0 111.384 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -95.28 140.87 22.57 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.13 -6.7 13.57 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 121.771 1.647 . . . . 0.0 112.43 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -102.13 -4.13 26.38 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.55 1.14 . . . . 0.0 112.975 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 14.7 p30 -78.05 164.12 25.31 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.03 0.832 . . . . 0.0 110.947 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 10.8 p90 -157.46 173.22 17.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.37 136.71 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.086 0.954 . . . . 0.0 108.558 168.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.19 130.03 9.38 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.15 104.38 16.93 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -104.15 148.89 25.76 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.519 0.728 . . . . 0.0 110.634 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -94.29 123.14 37.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.218 1.007 . . . . 0.0 109.072 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 137' ' ' LYS . 24.6 mm -67.65 90.57 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -139.35 130.35 26.4 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 109.681 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -73.37 97.59 2.54 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -157.7 -168.38 2.53 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -35.92 119.45 0.68 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.788 1.635 . . . . 0.0 112.61 173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.89 -32.55 6.42 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 124.432 3.421 . . . . 0.0 116.822 -167.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.47 -39.51 15.14 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.763 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 p30 32.54 58.22 0.4 Allowed 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 125.743 1.617 . . . . 0.0 112.907 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -58.82 106.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.001 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -152.99 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.766 1.226 . . . . 0.0 108.844 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.04 175.42 9.54 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.179 0.592 . . . . 0.0 110.129 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 p -140.26 160.24 40.4 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.596 -0.69 . . . . 0.0 110.383 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 8.1 mmpt? -84.7 157.84 20.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.483 0.658 . . . . 0.0 112.068 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.15 -165.98 1.41 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.54 -171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -50.79 147.7 4.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.856 1.262 . . . . 0.0 112.404 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.62 8.41 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.682 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.53 27.87 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 123.91 0.884 . . . . 0.0 109.954 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.0 p -79.07 47.57 0.79 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.05 1.34 . . . . 0.0 112.005 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.59 56.46 3.88 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -113.63 130.54 56.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.134 0.974 . . . . 0.0 109.452 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -71.58 -63.07 1.19 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.835 0.454 . . . . 0.0 111.207 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -117.94 122.01 42.16 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.09 -174.52 34.87 Favored Glycine 0 C--N 1.337 0.595 0 O-C-N 123.561 0.538 . . . . 0.0 112.411 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.97 145.27 25.46 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.417 0.687 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.494 HG13 ' HH2' ' A' ' 80' ' ' TRP . 50.2 mt -121.28 113.56 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 77' ' ' ILE . 10.2 p -82.21 144.57 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -164.5 119.29 1.43 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.158 0.983 . . . . 0.0 108.86 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -82.54 120.0 24.96 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HD22 ' A' ' 76' ' ' LEU . 13.5 mt -80.75 118.68 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -108.36 146.05 32.81 Favored Pre-proline 0 C--O 1.243 0.746 0 C-N-CA 124.245 1.018 . . . . 0.0 108.309 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.08 80.48 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.716 2.277 . . . . 0.0 112.433 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.48 -168.02 44.32 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.075 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.19 -20.38 43.5 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.584 2.189 . . . . 0.0 111.877 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.26 -33.11 32.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.756 0.823 . . . . 0.0 110.504 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.485 ' HA ' HG12 ' A' ' 136' ' ' ILE . 85.6 m-85 -109.73 81.42 1.44 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 82.1 mtp -128.27 -17.58 4.23 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.01 0.924 . . . . 0.0 111.621 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 136' ' ' ILE . 27.3 mt-10 -65.61 154.11 89.08 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.831 0.852 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.9 -24.28 75.61 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.146 1.898 . . . . 0.0 111.786 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -156.14 104.73 2.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 131' ' ' PHE . 3.8 mp -90.76 126.93 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.749 1.219 . . . . 0.0 108.311 173.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -100.18 124.23 45.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.5 pt -118.38 167.4 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.426 0.29 . . . . 0.0 110.359 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 26.6 p -157.4 128.37 6.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.481 0.713 . . . . 0.0 109.379 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -91.76 138.24 31.72 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.513 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' A' ' 153' ' ' THR . 97.1 mttt -134.56 104.48 6.1 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.398 0.679 . . . . 0.0 109.869 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.97 118.46 16.95 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.15 141.11 40.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 0.0 108.93 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -82.38 148.1 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.559 0.743 . . . . 0.0 109.612 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 90' ' ' ASP . . . -60.57 -45.26 96.66 Favored Glycine 0 C--N 1.347 1.183 0 O-C-N 123.636 0.585 . . . . 0.0 113.192 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 mm -65.31 118.62 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.72 0.408 . . . . 0.0 109.976 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t 70.3 -5.49 1.34 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.264 1.426 . . . . 0.0 113.317 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.08 28.6 70.83 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 117.674 0.216 . . . . 0.0 112.977 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.87 139.01 50.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.511 0.724 . . . . 0.0 111.31 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.79 118.91 9.0 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.704 HH12 HG12 ' A' ' 86' ' ' VAL . 45.2 ttt180 -103.97 -41.3 5.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.714 1.205 . . . . 0.0 109.916 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -160.8 158.37 28.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.867 0.867 . . . . 0.0 110.689 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' HG2' ' A' ' 141' ' ' LYS . 41.7 m -147.14 150.54 35.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.18 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 67.0 p -93.44 148.16 35.02 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 0.0 109.188 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.86 153.24 12.06 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.844 2.363 . . . . 0.0 112.389 161.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 25.7 p -61.74 113.49 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.506 0.722 . . . . 0.0 110.974 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.47 117.58 30.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.076 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 20.3 m -77.18 98.42 5.09 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.157 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.55 93.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.987 0.915 . . . . 0.0 109.188 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -90.82 149.93 21.77 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -123.17 105.42 34.28 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 0.0 110.233 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.371 1.756 0 C-N-CA 123.147 2.565 . . . . 0.0 111.228 167.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 145.0 30.04 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.868 0.867 . . . . 0.0 109.521 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 m -69.66 127.34 32.61 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.58 0.752 . . . . 0.0 110.601 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 p -98.56 147.22 25.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.818 0.847 . . . . 0.0 111.15 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -131.02 119.29 21.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 170.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.7 p -132.82 179.85 5.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 110.574 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -139.24 165.83 26.15 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 110.596 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -69.29 -35.61 76.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.759 0.824 . . . . 0.0 110.006 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -153.69 141.48 20.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.266 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -102.84 21.97 14.62 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.226 0.611 . . . . 0.0 110.072 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.62 142.19 41.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.307 1.043 . . . . 0.0 108.962 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -150.34 145.7 26.29 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -130.57 126.81 37.69 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 HD12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 mm? -60.31 118.3 6.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.138 0.575 . . . . 0.0 110.293 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.93 -14.61 9.02 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.07 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.44 153.14 27.05 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.072 0.436 . . . . 0.0 110.798 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.43 -8.4 58.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.662 0.785 . . . . 0.0 111.632 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -73.68 107.54 6.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.078 0.551 . . . . 0.0 110.244 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -75.64 150.8 37.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.274 0.63 . . . . 0.0 109.584 172.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 63' ' ' ALA . 4.5 tt -108.61 127.8 54.27 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.61 126.22 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.558 0.743 . . . . 0.0 109.41 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 120' ' ' GLN . 43.5 mm -100.03 109.69 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.264 1.026 . . . . 0.0 109.402 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 61' ' ' LEU . 80.0 m-85 -95.79 154.15 17.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.305 1.042 . . . . 0.0 109.994 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -153.09 150.27 28.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.72 0.408 . . . . 0.0 111.035 172.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 98.59 4.97 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.87 1.268 . . . . 0.0 108.476 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mm -89.23 103.86 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.35 -16.88 60.89 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.778 0.831 . . . . 0.0 112.129 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.84 173.24 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.283 1.033 . . . . 0.0 109.132 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.6 161.39 1.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.048 0.939 . . . . 0.0 113.388 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.66 153.85 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.481 1.113 . . . . 0.0 110.048 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.37 159.74 44.42 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.276 1.031 . . . . 0.0 108.985 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.0 -17.77 55.88 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.12 1.88 . . . . 0.0 112.044 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -81.88 -2.42 51.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 112.423 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.3 148.05 49.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.358 0.663 . . . . 0.0 110.086 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -153.55 153.09 31.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.516 0.326 . . . . 0.0 110.72 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.98 135.17 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 108' ' ' SER . . . -108.07 133.23 11.54 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 172.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.72 106.74 18.7 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 143' ' ' TYR . 71.6 m-85 -115.15 143.68 44.84 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.572 0.749 . . . . 0.0 109.708 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -86.18 145.19 27.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.616 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.62 96.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -122.77 120.03 32.37 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.41 87.62 0.64 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 166.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.41 ' HB3' HD21 ' A' ' 104' ' ' ASN . 18.2 t-20 -161.74 -171.87 3.09 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 113.536 -1.666 . . . . 0.0 107.607 -165.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 m -41.17 117.36 1.56 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.56 -21.33 10.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.854 3.036 . . . . 0.0 115.332 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.86 79.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.992 0.517 . . . . 0.0 111.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 100' ' ' ASN . 8.9 m120 39.95 64.17 0.93 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.221 1.408 . . . . 0.0 112.391 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.52 106.14 0.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.417 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.36 -157.13 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.205 1.002 . . . . 0.0 109.247 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.34 171.49 11.15 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.327 0.651 . . . . 0.0 110.529 -166.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 36.8 p -145.24 145.2 31.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.685 0.794 . . . . 0.0 110.122 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -85.66 157.08 20.42 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.808 0.813 . . . . 0.0 112.389 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.75 -164.77 1.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.442 -173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.5 152.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.239 1.416 . . . . 0.0 114.042 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.32 -15.78 29.96 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.594 -168.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 m -100.45 25.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.675 1.19 . . . . 0.0 110.343 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -78.29 26.72 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.667 1.187 . . . . 0.0 113.137 -168.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.92 61.09 2.76 Favored Glycine 0 C--N 1.343 0.958 0 O-C-N 122.01 -0.431 . . . . 0.0 112.267 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -100.7 135.1 42.67 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 110.258 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.872 0.869 . . . . 0.0 111.153 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -150.79 135.84 17.57 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.18 39.55 Favored Glycine 0 C--O 1.241 0.55 0 O-C-N 123.687 0.617 . . . . 0.0 111.959 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.56 153.5 33.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.938 0.495 . . . . 0.0 110.861 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.03 114.93 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.771 0.828 . . . . 0.0 108.82 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.16 120.4 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -142.35 122.48 13.77 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -79.5 126.62 31.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 159' ' ' VAL . 44.7 mt -80.36 100.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.1 140.04 23.24 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.537 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 70' ' ' LEU . 60.6 Cg_endo -68.63 94.94 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.449 2.1 . . . . 0.0 111.783 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.72 -169.96 46.53 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.435 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.59 -23.56 74.81 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.946 2.431 . . . . 0.0 112.365 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.59 -39.34 45.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.553 1.141 . . . . 0.0 110.654 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.54 81.25 3.9 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.191 0.52 . . . . 0.0 109.683 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 76.5 mtp -129.11 6.8 5.42 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.002 0.921 . . . . 0.0 110.972 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 33.9 mt-10 -76.78 158.35 80.76 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.641 0.776 . . . . 0.0 109.506 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.4 -21.07 26.79 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.99 1.794 . . . . 0.0 111.464 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.63 104.64 3.22 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.233 1.013 . . . . 0.0 108.721 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 3.8 mp -84.39 150.37 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 114.73 10.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.23 162.84 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 122.925 0.49 . . . . 0.0 111.258 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.06 131.42 12.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 0.0 108.976 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.12 138.98 31.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.44 1.096 . . . . 0.0 109.639 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 153' ' ' THR . 92.9 mttt -131.79 104.46 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 151' ' ' ARG . 34.1 t80 -75.64 97.62 3.84 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' A' ' 95' ' ' TYR . 93.2 m-85 -82.82 153.71 25.06 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.004 0.522 . . . . 0.0 109.734 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -92.28 166.74 12.45 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.18 -18.04 33.3 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 114.75 0.66 . . . . 0.0 114.75 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.12 132.25 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -62.87 108.85 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.177 0.991 . . . . 0.0 111.504 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.98 -9.03 70.46 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.938 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.36 109.47 6.91 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.077 0.551 . . . . 0.0 110.739 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.1 tp -86.36 110.66 19.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.295 0.638 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.459 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 8.4 tpm_? -83.59 -44.4 14.63 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.054 0.542 . . . . 0.0 110.998 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.28 160.6 40.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.849 0.46 . . . . 0.0 111.171 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 141' ' ' LYS . 93.4 m -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.529 1.132 . . . . 0.0 109.739 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.1 p -86.12 154.43 57.59 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.583 0.753 . . . . 0.0 109.187 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.59 169.21 14.76 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.871 1.714 . . . . 0.0 111.387 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 21.4 p -64.7 117.85 8.06 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.775 0.83 . . . . 0.0 112.602 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.62 119.25 33.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 124.146 0.979 . . . . 0.0 108.475 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -80.52 100.26 8.47 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 109.542 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' ILE . 21.2 t -99.93 95.9 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.826 0.85 . . . . 0.0 108.914 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -88.75 143.81 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.574 0.75 . . . . 0.0 110.192 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' HB2' HD23 ' A' ' 70' ' ' LEU . 59.0 t30 -128.43 111.53 19.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.377 2.029 0 C-N-CA 123.037 2.491 . . . . 0.0 110.947 177.727 . . . . . . . . 1 1 . 1 stop_ save_